| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.848 | 0.003 | 0.99 | DNA synthesis inhibitor | 0.898 0.002 DBMET03580 0.864 0.002 DBMET00656 0.546 0.01 DBMET00449 0.369 0.026 DBMET03581 0.915 0.002 DBMET03584 0.966 0.001 DBMET03586 0.911 0.002 DBMET03591 0.295 0.045 DBMET03582 0.968 0.001 DBMET03585 0.985 0.001 DBMET03589 0.355 0.029 DB03904 0.307 0.041 DBMET03583 0.986 0.001 DBMET03587 0.989 0.001 DBMET03590 0.99 0.001 DBMET03588 0.979 0.001 DBMET03592 | DBMET03588 | |
| 0.754 | 0.001 | 0.938 | Antimetabolite | 0.622 0.002 DBMET03580 0.552 0.002 DBMET00656 0.244 0.007 DBMET00449 0.101 0.016 DBMET03581 0.728 0.001 DBMET03584 0.896 0.001 DBMET03586 0.725 0.001 DBMET03591 0.112 0.015 DBMET03582 0.897 0.001 DBMET03585 0.934 0.001 DBMET03589 0.069 0.022 DB03904 0.113 0.015 DBMET03583 0.934 0.001 DBMET03587 0.938 0.001 DBMET03590 0.938 0.001 DBMET03588 0.905 0.001 DBMET03592 | DBMET03588 | |
| 0.632 | 0.007 | 0.632 | DNA damaging | 0.423 0.024 DBMET03580 0.503 0.014 DBMET00656 0.363 0.037 DBMET00449 0.613 0.008 DBMET03584 0.429 0.022 DBMET03586 0.533 0.011 DBMET03591 0.502 0.014 DBMET03585 0.424 0.023 DBMET03589 0.299 0.057 DB03904 0.497 0.014 DBMET03587 0.373 0.035 DBMET03590 0.442 0.02 DBMET03588 0.206 0.111 DBMET03592 | ||
| 0.588 | 0.006 | 0.924 | RNA-directed DNA polymerase inhibitor | 0.718 0.002 DBMET03580 0.623 0.004 DBMET00656 0.347 0.024 DBMET00449 0.476 0.012 DBMET03581 0.672 0.003 DBMET03584 0.806 0.001 DBMET03586 0.655 0.003 DBMET03591 0.174 0.144 DBMET03582 0.836 0.001 DBMET03585 0.889 0.001 DBMET03589 0.352 0.024 DB03904 0.223 0.071 DBMET03583 0.909 0.001 DBMET03587 0.909 0.001 DBMET03590 0.924 0.001 DBMET03588 0.781 0.002 DBMET03592 | DBMET03588 | |
| 0.582 | 0.013 | 0.616 | Immunomodulator | 0.616 0.01 DBMET03580 0.266 0.103 DBMET00656 0.598 0.012 DBMET03581 0.307 0.079 DBMET03584 0.428 0.036 DBMET03586 0.395 0.045 DBMET03591 0.288 0.089 DBMET03582 0.351 0.059 DBMET03585 0.486 0.025 DBMET03589 0.547 0.017 DBMET03583 0.412 0.04 DBMET03587 0.456 0.03 DBMET03590 0.387 0.048 DBMET03588 0.394 0.045 DBMET03592 | DBMET03580 | |
| 0.491 | 0.005 | 0.654 | Alkylator | 0.328 0.011 DBMET03580 0.448 0.006 DBMET00656 0.233 0.019 DBMET00449 0.543 0.004 DBMET03584 0.608 0.004 DBMET03586 0.483 0.005 DBMET03591 0.131 0.058 DBMET03582 0.654 0.003 DBMET03585 0.555 0.004 DBMET03589 0.189 0.03 DB03904 0.096 0.094 DBMET03583 0.608 0.004 DBMET03587 0.506 0.005 DBMET03590 0.565 0.004 DBMET03588 0.464 0.005 DBMET03592 | DBMET03585 | |
| 0.51 | 0.038 | 0.623 | Antibacterial | 0.584 0.022 DBMET03580 0.593 0.02 DBMET00656 0.339 0.108 DBMET00449 0.572 0.024 DBMET03584 0.563 0.026 DBMET03586 0.578 0.023 DBMET03591 0.302 0.134 DBMET03582 0.556 0.027 DBMET03585 0.543 0.03 DBMET03589 0.271 0.158 DB03904 0.435 0.062 DBMET03583 0.534 0.032 DBMET03587 0.512 0.037 DBMET03590 0.502 0.04 DBMET03588 0.623 0.016 DBMET03592 | DBMET03592 | |
| 0.457 | 0.004 | 0.565 | Peptidyltransferase inhibitor | 0.565 0.003 DBMET03580 0.469 0.004 DBMET00656 0.227 0.069 DBMET00449 0.211 0.085 DBMET03581 0.413 0.006 DBMET03584 0.337 0.014 DBMET03586 0.395 0.007 DBMET03591 0.226 0.07 DBMET03582 0.357 0.011 DBMET03585 0.319 0.019 DBMET03589 0.257 0.046 DB03904 0.304 0.023 DBMET03583 0.339 0.014 DBMET03587 0.313 0.02 DBMET03590 0.333 0.015 DBMET03588 0.319 0.019 DBMET03592 | DBMET03580 | |
| 0.449 | 0.047 | 0.555 | Immunosuppressant | 0.404 0.061 DBMET03580 0.452 0.046 DBMET00656 0.466 0.043 DBMET00449 0.455 0.046 DBMET03584 0.555 0.02 DBMET03586 0.453 0.046 DBMET03591 0.228 0.168 DBMET03582 0.553 0.02 DBMET03585 0.494 0.035 DBMET03589 0.353 0.085 DBMET03583 0.494 0.035 DBMET03587 0.485 0.037 DBMET03590 0.485 0.037 DBMET03588 0.523 0.027 DBMET03592 | DBMET03586 | |
| 0.439 | 0.039 | 0.598 | Immunostimulant | 0.404 0.048 DBMET03580 0.349 0.065 DBMET00656 0.403 0.049 DBMET03584 0.538 0.024 DBMET03586 0.42 0.044 DBMET03591 0.21 0.114 DBMET03582 0.519 0.027 DBMET03585 0.54 0.024 DBMET03589 0.25 0.096 DB03904 0.271 0.088 DBMET03583 0.521 0.026 DBMET03587 0.514 0.027 DBMET03590 0.492 0.03 DBMET03588 0.598 0.017 DBMET03592 | DBMET03592 | |
| 0.379 | 0.007 | 0.728 | DNA polymerase I inhibitor | 0.478 0.004 DBMET03580 0.378 0.007 DBMET00656 0.201 0.028 DBMET03581 0.507 0.004 DBMET03584 0.576 0.003 DBMET03586 0.445 0.005 DBMET03591 0.6 0.003 DBMET03585 0.685 0.002 DBMET03589 0.125 0.064 DBMET03583 0.698 0.001 DBMET03587 0.717 0.001 DBMET03590 0.728 0.001 DBMET03588 0.591 0.003 DBMET03592 | DBMET03588 | |
| 0.346 | 0.017 | 0.664 | DNA methylase inhibitor | 0.664 0.003 DBMET03580 0.437 0.009 DBMET00656 0.525 0.005 DBMET03584 0.524 0.005 DBMET03586 0.53 0.005 DBMET03591 0.52 0.005 DBMET03585 0.448 0.008 DBMET03589 0.162 0.107 DB03904 0.445 0.008 DBMET03587 0.398 0.011 DBMET03590 0.394 0.011 DBMET03588 0.224 0.064 DBMET03592 | DBMET03580 | |
| 0.324 | 0.011 | 0.699 | Adenylate cyclase inhibitor | 0.477 0.006 DBMET03580 0.374 0.009 DBMET00656 0.46 0.006 DBMET03584 0.642 0.003 DBMET03586 0.449 0.006 DBMET03591 0.645 0.003 DBMET03585 0.684 0.002 DBMET03589 0.142 0.05 DB03904 0.106 0.079 DBMET03583 0.686 0.002 DBMET03587 0.697 0.002 DBMET03590 0.699 0.002 DBMET03588 0.645 0.003 DBMET03592 | DBMET03588 | |
| 0.369 | 0.066 | 0.68 | Vasodilator, peripheral | 0.245 0.13 DBMET03580 0.333 0.081 DBMET00656 0.333 0.081 DBMET03584 0.446 0.042 DBMET03586 0.507 0.026 DBMET03591 0.196 0.18 DBMET03582 0.262 0.119 DBMET03585 0.653 0.01 DBMET03589 0.247 0.129 DB03904 0.325 0.085 DBMET03583 0.482 0.032 DBMET03587 0.68 0.008 DBMET03590 0.53 0.023 DBMET03588 0.243 0.132 DBMET03592 | DBMET03590 | |
| 0.34 | 0.068 | 0.464 | Cholesterol antagonist | 0.294 0.095 DBMET03580 0.343 0.067 DBMET00656 0.263 0.116 DBMET03584 0.195 0.169 DBMET03586 0.464 0.038 DBMET03591 0.333 0.072 DB03904 0.257 0.12 DBMET03583 | DBMET03591 | |
| 0.346 | 0.084 | 0.346 | Toll-Like receptor agonist | 0.281 0.123 DB03904 | ||
| 0.375 | 0.127 | 0.849 | Caspase 9 stimulant | 0.408 0.106 DBMET03580 0.594 0.037 DBMET00656 0.289 0.206 DBMET00449 0.568 0.041 DBMET03584 0.849 0.005 DBMET03586 0.749 0.018 DBMET03591 0.795 0.012 DBMET03585 0.702 0.024 DBMET03589 0.385 0.12 DB03904 0.287 0.208 DBMET03583 0.518 0.053 DBMET03587 0.629 0.032 DBMET03590 0.474 0.071 DBMET03588 0.342 0.152 DBMET03592 | DBMET03586 | |
| 0.374 | 0.127 | 0.635 | Apoptosis agonist | 0.42 0.104 DBMET03580 0.616 0.046 DBMET00656 0.635 0.042 DBMET00449 0.576 0.055 DBMET03584 0.577 0.054 DBMET03586 0.595 0.05 DBMET03591 0.558 0.058 DBMET03585 0.505 0.073 DBMET03589 0.49 0.077 DBMET03587 0.48 0.081 DBMET03590 0.466 0.085 DBMET03588 0.454 0.089 DBMET03592 | DBMET00449 | |
| 0.256 | 0.009 | 0.256 | Aurora-C kinase inhibitor | 0.124 0.097 DBMET03580 | ||
| 0.327 | 0.094 | 0.327 | Toll-Like receptor 7 agonist | 0.277 0.126 DB03904 | ||
| 0.235 | 0.008 | 0.803 | Phosphofructokinase-1 inhibitor | 0.459 0.003 DBMET03580 0.35 0.004 DBMET00656 0.086 0.038 DBMET00449 0.067 0.05 DBMET03581 0.291 0.006 DBMET03584 0.699 0.001 DBMET03586 0.455 0.003 DBMET03591 0.122 0.025 DBMET03582 0.515 0.002 DBMET03585 0.777 0.001 DBMET03589 0.219 0.009 DB03904 0.195 0.012 DBMET03583 0.617 0.001 DBMET03587 0.803 0.001 DBMET03590 0.644 0.001 DBMET03588 0.583 0.002 DBMET03592 | DBMET03590 | |
| 0.305 | 0.083 | 0.441 | Vasodilator, coronary | 0.278 0.107 DBMET03580 0.275 0.11 DBMET00656 0.195 0.187 DBMET03584 0.296 0.091 DBMET03586 0.384 0.041 DBMET03591 0.411 0.032 DBMET03589 0.271 0.114 DB03904 0.228 0.156 DBMET03587 0.441 0.025 DBMET03590 0.257 0.128 DBMET03588 | DBMET03590 | |
| 0.371 | 0.158 | 0.848 | Antiinflammatory | 0.848 0.009 DBMET03581 | DBMET03581 | |
| 0.21 | 0.008 | 0.469 | DNA repair enzyme inhibitor | 0.373 0.004 DBMET03580 0.278 0.005 DBMET00656 0.136 0.046 DBMET00449 0.163 0.021 DBMET03581 0.359 0.004 DBMET03584 0.456 0.003 DBMET03586 0.347 0.004 DBMET03591 0.469 0.003 DBMET03585 0.259 0.005 DBMET03589 0.145 0.036 DB03904 0.107 0.105 DBMET03583 0.272 0.005 DBMET03587 0.227 0.006 DBMET03590 0.236 0.006 DBMET03588 0.14 0.042 DBMET03592 | DBMET03585 | |
| 0.204 | 0.009 | 0.239 | Transcription factor NF kappa B stimulant | 0.195 0.01 DBMET03580 0.128 0.022 DBMET00656 0.12 0.025 DBMET03584 0.168 0.013 DBMET03586 0.16 0.014 DBMET03591 0.132 0.021 DBMET03585 0.213 0.008 DBMET03589 0.169 0.013 DBMET03587 0.204 0.009 DBMET03590 0.163 0.013 DBMET03588 0.239 0.006 DBMET03592 | DBMET03592 | |
| 0.187 | 0.008 | 0.712 | Carbamoyl phosphate synthetase inhibitor | 0.492 0.002 DBMET03580 0.225 0.006 DBMET00656 0.09 0.024 DBMET00449 0.086 0.026 DBMET03581 0.181 0.008 DBMET03584 0.655 0.001 DBMET03586 0.375 0.003 DBMET03591 0.265 0.005 DBMET03582 0.536 0.002 DBMET03585 0.699 0.001 DBMET03589 0.403 0.003 DB03904 0.214 0.007 DBMET03583 0.6 0.001 DBMET03587 0.712 0.001 DBMET03590 0.618 0.001 DBMET03588 0.469 0.003 DBMET03592 | DBMET03590 | |
| 0.216 | 0.041 | 0.956 | Cytidine deaminase inhibitor | 0.423 0.009 DBMET03580 0.61 0.004 DBMET00656 0.261 0.027 DBMET00449 0.161 0.068 DBMET03581 0.769 0.002 DBMET03584 0.863 0.002 DBMET03586 0.771 0.002 DBMET03591 0.861 0.002 DBMET03585 0.93 0.001 DBMET03589 0.246 0.03 DB03904 0.929 0.001 DBMET03587 0.956 0.001 DBMET03590 0.954 0.001 DBMET03588 0.743 0.003 DBMET03592 | DBMET03590 | |
| 0.191 | 0.019 | 0.74 | UDP-glucose 4-epimerase inhibitor | 0.466 0.003 DBMET03580 0.568 0.001 DBMET00656 0.267 0.012 DBMET00449 0.375 0.007 DBMET03581 0.604 0.001 DBMET03584 0.697 0 DBMET03586 0.612 0.001 DBMET03591 0.112 0.049 DBMET03582 0.689 0 DBMET03585 0.729 0 DBMET03589 0.283 0.011 DB03904 0.166 0.024 DBMET03583 0.721 0 DBMET03587 0.74 0 DBMET03590 0.732 0 DBMET03588 0.637 0.001 DBMET03592 | DBMET03590 | |
| 0.186 | 0.016 | 0.662 | DNA directed RNA polymerase inhibitor | 0.352 0.005 DBMET03580 0.343 0.005 DBMET00656 0.189 0.015 DBMET00449 0.109 0.047 DBMET03581 0.371 0.005 DBMET03584 0.459 0.004 DBMET03586 0.338 0.006 DBMET03591 0.486 0.004 DBMET03585 0.595 0.004 DBMET03589 0.611 0.004 DBMET03587 0.647 0.003 DBMET03590 0.662 0.003 DBMET03588 0.368 0.005 DBMET03592 | DBMET03588 | |
| 0.238 | 0.07 | 0.447 | Cyclic AMP phosphodiesterase inhibitor | 0.244 0.066 DBMET03580 0.328 0.032 DBMET00656 0.204 0.09 DBMET00449 0.229 0.075 DBMET03581 0.22 0.08 DBMET03584 0.247 0.065 DBMET03586 0.447 0.011 DBMET03591 0.205 0.09 DB03904 | DBMET03591 | |
| 0.167 | 0.013 | 0.297 | Adenosine A2a receptor antagonist | 0.297 0.005 DBMET03580 0.127 0.019 DBMET00656 0.112 0.022 DBMET03584 0.26 0.007 DBMET03591 0.053 0.052 DB03904 | DBMET03580 | |
| 0.164 | 0.015 | 0.593 | Aminoacyl-tRNA synthetase inhibitor | 0.307 0.006 DBMET03580 0.2 0.011 DBMET00656 0.151 0.019 DBMET03584 0.402 0.004 DBMET03586 0.27 0.007 DBMET03591 0.349 0.005 DBMET03585 0.538 0.003 DBMET03589 0.091 0.057 DB03904 0.462 0.003 DBMET03587 0.593 0.003 DBMET03590 0.514 0.003 DBMET03588 0.396 0.004 DBMET03592 | DBMET03590 | |
| 0.157 | 0.011 | 0.371 | Ribonucleotide reductase inhibitor | 0.118 0.017 DBMET03580 0.075 0.029 DBMET00656 0.156 0.011 DBMET03584 0.229 0.006 DBMET03586 0.143 0.013 DBMET03591 0.071 0.031 DBMET03582 0.256 0.005 DBMET03585 0.326 0.004 DBMET03589 0.085 0.025 DB03904 0.062 0.035 DBMET03583 0.352 0.003 DBMET03587 0.349 0.004 DBMET03590 0.371 0.003 DBMET03588 0.164 0.01 DBMET03592 | DBMET03588 | |
| 0.26 | 0.119 | 0.41 | Antithrombotic | 0.206 0.17 DBMET00656 0.192 0.188 DBMET03584 0.41 0.047 DBMET03586 0.256 0.121 DBMET03591 0.321 0.076 DBMET03585 0.352 0.064 DBMET03589 0.247 0.128 DB03904 0.222 0.151 DBMET03583 0.28 0.103 DBMET03587 0.309 0.082 DBMET03590 0.243 0.131 DBMET03588 0.336 0.069 DBMET03592 | DBMET03586 | |
| 0.162 | 0.023 | 0.543 | Adenylate kinase inhibitor | 0.322 0.006 DBMET03580 0.238 0.011 DBMET00656 0.111 0.052 DBMET00449 0.102 0.064 DBMET03581 0.149 0.027 DBMET03584 0.494 0.001 DBMET03586 0.314 0.006 DBMET03591 0.285 0.008 DBMET03582 0.388 0.004 DBMET03585 0.531 0.001 DBMET03589 0.417 0.003 DB03904 0.279 0.008 DBMET03583 0.435 0.002 DBMET03587 0.543 0.001 DBMET03590 0.449 0.002 DBMET03588 0.385 0.004 DBMET03592 | DBMET03590 | |
| 0.155 | 0.016 | 0.283 | Adenosine A2 receptor antagonist | 0.283 0.006 DBMET03580 0.13 0.02 DBMET00656 0.098 0.028 DBMET03584 0.259 0.007 DBMET03591 | DBMET03580 | |
| 0.172 | 0.034 | 0.172 | DNA intercalator | 0.114 0.062 DBMET03580 0.128 0.053 DBMET00656 0.098 0.076 DBMET00449 | ||
| 0.145 | 0.012 | 0.189 | Ribonucleoside-diphosphate reductase inhibitor | 0.102 0.019 DBMET03580 0.051 0.04 DBMET00656 0.12 0.016 DBMET03584 0.164 0.009 DBMET03586 0.11 0.017 DBMET03591 0.069 0.029 DBMET03582 0.172 0.009 DBMET03585 0.178 0.008 DBMET03589 0.083 0.024 DB03904 0.057 0.036 DBMET03583 0.189 0.007 DBMET03587 0.165 0.009 DBMET03590 0.173 0.009 DBMET03588 0.116 0.016 DBMET03592 | DBMET03587 | |
| 0.139 | 0.011 | 0.811 | Ornithine carbamoyltransferase inhibitor | 0.214 0.006 DBMET03580 0.142 0.01 DBMET00656 0.055 0.035 DBMET00449 0.047 0.043 DBMET03581 0.095 0.017 DBMET03584 0.694 0.002 DBMET03586 0.218 0.006 DBMET03591 0.238 0.005 DBMET03582 0.371 0.003 DBMET03585 0.789 0.001 DBMET03589 0.211 0.006 DB03904 0.195 0.007 DBMET03583 0.503 0.002 DBMET03587 0.811 0.001 DBMET03590 0.555 0.002 DBMET03588 0.295 0.004 DBMET03592 | DBMET03590 | |
| 0.197 | 0.07 | 0.471 | DNA methyltransferase I inhibitor | 0.471 0.005 DBMET03580 0.287 0.031 DBMET00656 0.371 0.012 DBMET03584 0.382 0.01 DBMET03591 0.141 0.114 DB03904 | DBMET03580 | |
| 0.151 | 0.041 | 0.331 | Topoisomerase I inhibitor | 0.219 0.022 DBMET03580 0.291 0.012 DBMET00656 0.212 0.024 DBMET03584 0.187 0.03 DBMET03586 0.331 0.009 DBMET03591 0.088 0.081 DBMET03585 0.136 0.047 DBMET03589 0.121 0.055 DBMET03590 0.097 0.073 DBMET03592 | DBMET03591 | |
| 0.208 | 0.098 | 0.328 | Vasodilator | 0.177 0.125 DBMET00656 0.248 0.07 DBMET03586 0.212 0.095 DBMET03591 0.155 0.15 DBMET03585 0.306 0.046 DBMET03589 0.214 0.094 DBMET03587 0.328 0.04 DBMET03590 0.233 0.08 DBMET03588 | DBMET03590 | |
| 0.121 | 0.011 | 0.768 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | 0.403 0.002 DBMET03580 0.342 0.003 DBMET00656 0.104 0.013 DBMET00449 0.072 0.025 DBMET03581 0.458 0.001 DBMET03584 0.675 0 DBMET03586 0.493 0.001 DBMET03591 0.057 0.038 DBMET03582 0.634 0.001 DBMET03585 0.746 0 DBMET03589 0.147 0.009 DB03904 0.091 0.016 DBMET03583 0.708 0 DBMET03587 0.768 0 DBMET03590 0.732 0 DBMET03588 0.522 0.001 DBMET03592 | DBMET03590 | |
| 0.109 | 0.008 | 0.554 | Purinergic P2Y antagonist | 0.093 0.01 DBMET03580 0.087 0.011 DBMET00656 0.092 0.01 DBMET03584 0.44 0.002 DBMET03586 0.117 0.007 DBMET03591 0.409 0.002 DBMET03585 0.523 0.001 DBMET03589 0.039 0.038 DB03904 0.485 0.002 DBMET03587 0.554 0.001 DBMET03590 0.515 0.001 DBMET03588 0.461 0.002 DBMET03592 | DBMET03590 | |
| 0.115 | 0.016 | 0.832 | Argininosuccinate synthase inhibitor | 0.351 0.003 DBMET03580 0.297 0.004 DBMET00656 0.089 0.022 DBMET00449 0.064 0.034 DBMET03581 0.362 0.003 DBMET03584 0.75 0.001 DBMET03586 0.363 0.003 DBMET03591 0.117 0.016 DBMET03582 0.749 0.001 DBMET03585 0.813 0.001 DBMET03589 0.213 0.007 DB03904 0.183 0.009 DBMET03583 0.812 0.001 DBMET03587 0.832 0 DBMET03590 0.831 0 DBMET03588 0.467 0.002 DBMET03592 | DBMET03590 | |
| 0.154 | 0.062 | 0.22 | Cell wall synthesis inhibitor | 0.211 0.026 DBMET03580 0.165 0.051 DBMET00656 0.113 0.11 DBMET03581 0.177 0.042 DBMET03586 0.176 0.042 DBMET03591 0.13 0.085 DBMET03582 0.177 0.042 DBMET03589 0.22 0.023 DB03904 0.153 0.063 DBMET03583 0.155 0.061 DBMET03590 0.167 0.05 DBMET03592 | DB03904 | |
| 0.09 | 0.007 | 0.97 | Thymidine kinase inhibitor | 0.139 0.004 DBMET03580 0.292 0.002 DBMET00656 0.087 0.008 DBMET00449 0.085 0.008 DBMET03581 0.758 0.001 DBMET03584 0.895 0.001 DBMET03586 0.696 0.001 DBMET03591 0.925 0 DBMET03585 0.954 0 DBMET03589 0.051 0.018 DB03904 0.965 0 DBMET03587 0.962 0 DBMET03590 0.97 0 DBMET03588 0.788 0.001 DBMET03592 | DBMET03588 | |
| 0.107 | 0.028 | 0.54 | HIV-1 reverse transcriptase inhibitor | 0.254 0.007 DBMET03580 0.228 0.008 DBMET00656 0.151 0.014 DBMET00449 0.241 0.007 DBMET03584 0.308 0.005 DBMET03586 0.22 0.008 DBMET03591 0.325 0.005 DBMET03585 0.47 0.004 DBMET03589 0.479 0.004 DBMET03587 0.533 0.004 DBMET03590 0.54 0.004 DBMET03588 0.297 0.005 DBMET03592 | DBMET03588 | |
| 0.175 | 0.1 | 0.656 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.37 0.01 DBMET03580 0.371 0.01 DBMET00656 0.402 0.008 DBMET03584 0.624 0.002 DBMET03586 0.515 0.004 DBMET03591 0.519 0.004 DBMET03585 0.656 0.001 DBMET03589 0.253 0.041 DB03904 0.199 0.073 DBMET03583 0.596 0.003 DBMET03587 0.645 0.002 DBMET03590 0.574 0.003 DBMET03588 0.47 0.004 DBMET03592 | DBMET03589 | |
| 0.091 | 0.016 | 0.125 | Protein 50S ribosomal subunit inhibitor | 0.125 0.009 DBMET03580 0.118 0.01 DBMET00656 0.052 0.038 DBMET03584 0.07 0.024 DBMET03586 0.073 0.023 DBMET03591 0.052 0.038 DBMET03585 0.063 0.029 DBMET03589 0.046 0.045 DBMET03587 0.061 0.03 DBMET03590 0.083 0.018 DBMET03592 | DBMET03580 | |
| 0.092 | 0.031 | 0.218 | Adenosine A3 receptor antagonist | 0.169 0.011 DBMET03580 0.119 0.018 DBMET00656 0.116 0.019 DBMET03584 0.218 0.008 DBMET03591 0.088 0.034 DB03904 | DBMET03591 | |
| 0.066 | 0.005 | 0.874 | Uridine phosphorylase inhibitor | 0.086 0.003 DBMET03580 0.375 0.001 DBMET00656 0.129 0.002 DBMET00449 0.049 0.008 DBMET03581 0.683 0 DBMET03584 0.849 0 DBMET03586 0.657 0 DBMET03591 0.874 0 DBMET03585 0.565 0 DBMET03589 0.055 0.007 DB03904 0.025 0.022 DBMET03583 0.582 0 DBMET03587 0.526 0 DBMET03590 0.541 0 DBMET03588 0.366 0.001 DBMET03592 | DBMET03585 | |
| 0.07 | 0.011 | 0.506 | Thymidylate synthase inhibitor | 0.16 0.003 DBMET03580 0.221 0.002 DBMET00656 0.15 0.003 DBMET00449 0.046 0.033 DBMET03581 0.305 0.001 DBMET03584 0.453 0.001 DBMET03586 0.265 0.002 DBMET03591 0.506 0.001 DBMET03585 0.317 0.001 DBMET03589 0.076 0.009 DB03904 0.043 0.037 DBMET03583 0.367 0.001 DBMET03587 0.288 0.002 DBMET03590 0.335 0.001 DBMET03588 0.141 0.003 DBMET03592 | DBMET03585 | |
| 0.072 | 0.013 | 0.109 | Adenine nucleotide translocase inhibitor | 0.082 0.008 DBMET03580 0.107 0.004 DBMET00656 0.078 0.01 DBMET03584 0.109 0.004 DBMET03586 0.107 0.004 DBMET03591 0.083 0.008 DBMET03585 0.099 0.005 DBMET03589 0.076 0.011 DBMET03587 0.096 0.005 DBMET03590 0.074 0.012 DBMET03588 0.098 0.005 DBMET03592 | DBMET03586 | |
| 0.071 | 0.013 | 0.117 | Adenosine deaminase inhibitor | 0.095 0.006 DBMET03580 0.074 0.011 DBMET00656 0.108 0.005 DBMET03584 0.103 0.005 DBMET03586 0.111 0.004 DBMET03591 0.101 0.005 DBMET03585 0.117 0.004 DBMET03589 0.064 0.017 DB03904 0.047 0.033 DBMET03583 0.114 0.004 DBMET03587 0.109 0.004 DBMET03590 0.107 0.005 DBMET03588 0.08 0.009 DBMET03592 | DBMET03589 | |
| 0.126 | 0.077 | 0.163 | Interleukin 4 antagonist | 0.163 0.039 DBMET03580 | DBMET03580 | |
| 0.055 | 0.012 | 0.464 | Phosphoglycerate kinase inhibitor | 0.134 0.005 DBMET03580 0.053 0.013 DBMET00656 0.057 0.012 DBMET03584 0.371 0.002 DBMET03586 0.151 0.004 DBMET03591 0.04 0.02 DBMET03582 0.147 0.004 DBMET03585 0.442 0.001 DBMET03589 0.094 0.007 DB03904 0.04 0.019 DBMET03583 0.225 0.003 DBMET03587 0.464 0.001 DBMET03590 0.259 0.003 DBMET03588 0.143 0.005 DBMET03592 | DBMET03590 | |
| 0.081 | 0.043 | 0.818 | Glutamate dehydrogenase inhibitor | 0.369 0.004 DBMET03580 0.171 0.013 DBMET00656 0.074 0.051 DBMET00449 0.11 0.026 DBMET03584 0.728 0.002 DBMET03586 0.237 0.008 DBMET03591 0.257 0.007 DBMET03582 0.421 0.004 DBMET03585 0.802 0.001 DBMET03589 0.338 0.005 DB03904 0.272 0.006 DBMET03583 0.559 0.003 DBMET03587 0.818 0.001 DBMET03590 0.609 0.002 DBMET03588 0.333 0.005 DBMET03592 | DBMET03590 | |
| 0.074 | 0.04 | 0.085 | Selectin antagonist | 0.069 0.043 DBMET03580 0.082 0.035 DBMET00656 0.085 0.034 DBMET03591 0.078 0.038 DBMET03583 | DBMET03591 | |
| 0.069 | 0.036 | 0.09 | Interferon inducer | 0.063 0.047 DBMET03580 0.09 0.017 DB03904 | DB03904 | |
| 0.145 | 0.113 | 0.147 | Lipocortins synthesis antagonist | 0.139 0.123 DBMET00656 0.135 0.13 DBMET03584 0.147 0.109 DBMET03583 | DBMET03583 | |
| 0.04 | 0.008 | 0.098 | Adenosine A1 receptor agonist | 0.075 0.004 DBMET03580 0.059 0.005 DBMET00656 0.044 0.007 DBMET03584 0.069 0.004 DBMET03586 0.098 0.004 DBMET03591 0.038 0.008 DBMET03585 0.053 0.005 DBMET03589 0.033 0.01 DBMET03587 0.05 0.006 DBMET03590 0.032 0.01 DBMET03588 0.046 0.006 DBMET03592 | DBMET03591 | |
| 0.085 | 0.054 | 0.11 | Antineoplastic antibiotic | 0.108 0.043 DBMET03580 0.11 0.042 DBMET00656 | DBMET00656 | |
| 0.093 | 0.062 | 0.758 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.308 0.006 DBMET03580 0.551 0.002 DBMET00656 0.227 0.012 DBMET00449 0.139 0.03 DBMET03581 0.493 0.003 DBMET03584 0.746 0.001 DBMET03586 0.625 0.001 DBMET03591 0.131 0.034 DBMET03582 0.648 0.001 DBMET03585 0.758 0 DBMET03589 0.282 0.007 DB03904 0.22 0.013 DBMET03583 0.667 0.001 DBMET03587 0.746 0.001 DBMET03590 0.648 0.001 DBMET03588 0.706 0.001 DBMET03592 | DBMET03589 | |
| 0.037 | 0.008 | 0.745 | Thymidine phosphorylase inhibitor | 0.142 0.002 DBMET03580 0.353 0.001 DBMET00656 0.205 0.002 DBMET00449 0.038 0.007 DBMET03581 0.745 0.001 DBMET03584 0.597 0.001 DBMET03586 0.719 0.001 DBMET03591 0.632 0.001 DBMET03585 0.383 0.001 DBMET03589 0.078 0.004 DB03904 0.408 0.001 DBMET03587 0.337 0.001 DBMET03590 0.355 0.001 DBMET03588 0.156 0.002 DBMET03592 | DBMET03584 | |
| 0.035 | 0.007 | 0.466 | Thymidine kinase (Herpes simplex virus 1) inhibitor | 0.05 0.004 DBMET03580 0.169 0.002 DBMET00656 0.034 0.008 DBMET00449 0.045 0.004 DBMET03581 0.466 0.001 DBMET03584 0.356 0.001 DBMET03586 0.393 0.001 DBMET03591 0.419 0.001 DBMET03585 0.167 0.002 DBMET03589 0.029 0.013 DB03904 0.213 0.002 DBMET03587 0.138 0.002 DBMET03590 0.176 0.002 DBMET03588 0.069 0.003 DBMET03592 | DBMET03584 | |
| 0.037 | 0.01 | 0.297 | Purinergic P2Y12 antagonist | 0.021 0.018 DBMET03580 0.114 0.004 DBMET03586 0.028 0.013 DBMET03591 0.065 0.005 DBMET03585 0.259 0.003 DBMET03589 0.14 0.004 DBMET03587 0.297 0.003 DBMET03590 0.209 0.004 DBMET03588 0.168 0.004 DBMET03592 | DBMET03590 | |
| 0.137 | 0.111 | 0.402 | Interleukin 6 antagonist | 0.222 0.03 DBMET03580 0.302 0.014 DBMET00656 0.402 0.007 DBMET03584 0.197 0.043 DBMET03586 0.205 0.038 DBMET03591 0.367 0.009 DBMET03585 0.134 0.116 DBMET03589 0.269 0.02 DB03904 0.278 0.018 DBMET03587 0.258 0.022 DBMET03588 | DBMET03584 | |
| 0.03 | 0.005 | 0.039 | Isoleucine-tRNA ligase inhibitor | 0.039 0.003 DBMET03580 0.03 0.005 DBMET00656 0.025 0.01 DBMET03584 0.035 0.004 DBMET03591 0.028 0.007 DB03904 | DBMET03580 | |
| 0.036 | 0.011 | 0.387 | Purinergic P2T antagonist | 0.029 0.013 DBMET03580 0.022 0.015 DBMET00656 0.119 0.004 DBMET03586 0.037 0.011 DBMET03591 0.081 0.006 DBMET03585 0.342 0.003 DBMET03589 0.189 0.004 DBMET03587 0.387 0.003 DBMET03590 0.268 0.004 DBMET03588 0.329 0.003 DBMET03592 | DBMET03590 | |
| 0.129 | 0.104 | 0.2 | Adenylate cyclase stimulant | 0.16 0.048 DBMET03580 0.152 0.06 DBMET00656 0.134 0.094 DBMET03584 0.171 0.034 DBMET03586 0.174 0.031 DBMET03591 0.15 0.062 DBMET03582 0.131 0.1 DBMET03585 0.143 0.075 DBMET03589 0.2 0.014 DB03904 0.191 0.018 DBMET03583 0.133 0.094 DBMET03590 | DB03904 | |
| 0.04 | 0.018 | 0.041 | Ceramide glucosyltransferase inhibitor | 0.041 0.016 DBMET03591 0.037 0.023 DBMET03589 0.032 0.031 DBMET03590 0.033 0.029 DBMET03592 | DBMET03591 | |
| 0.039 | 0.017 | 0.231 | Purinergic P2Y2 antagonist | 0.06 0.008 DBMET03580 0.089 0.005 DBMET00656 0.034 0.023 DBMET00449 0.056 0.009 DBMET03584 0.18 0.002 DBMET03586 0.092 0.004 DBMET03591 0.156 0.003 DBMET03585 0.219 0.001 DBMET03589 0.199 0.002 DBMET03587 0.231 0.001 DBMET03590 0.21 0.001 DBMET03588 0.169 0.002 DBMET03592 | DBMET03590 | |
| 0.143 | 0.121 | 0.506 | Phospholipase C inhibitor | 0.139 0.131 DBMET03580 0.506 0.006 DBMET03586 0.159 0.09 DBMET03591 0.191 0.05 DBMET03582 0.282 0.02 DBMET03585 0.262 0.023 DBMET03589 0.479 0.007 DB03904 0.215 0.036 DBMET03583 0.169 0.074 DBMET03587 0.229 0.03 DBMET03590 0.156 0.094 DBMET03588 0.222 0.033 DBMET03592 | DBMET03586 | |
| 0.033 | 0.016 | 0.328 | Purinergic P2X agonist | 0.054 0.008 DBMET03580 0.045 0.011 DBMET00656 0.028 0.018 DBMET03584 0.143 0.002 DBMET03586 0.049 0.01 DBMET03591 0.108 0.003 DBMET03585 0.268 0.001 DBMET03589 0.192 0.002 DBMET03587 0.328 0.001 DBMET03590 0.244 0.001 DBMET03588 0.131 0.002 DBMET03592 | DBMET03590 | |
| 0.049 | 0.032 | 0.066 | Cytokine production stimulant | 0.066 0.009 DB03904 | DB03904 | |
| 0.076 | 0.059 | 0.107 | Interferon agonist | 0.107 0.024 DB03904 0.072 0.067 DBMET03583 | DB03904 | |
| 0.023 | 0.006 | 0.715 | Purinergic P2 agonist | 0.047 0.003 DBMET03580 0.056 0.003 DBMET00656 0.045 0.003 DBMET03584 0.157 0.001 DBMET03586 0.06 0.002 DBMET03591 0.115 0.001 DBMET03585 0.534 0.001 DBMET03589 0.334 0.001 DBMET03587 0.715 0.001 DBMET03590 0.485 0.001 DBMET03588 0.232 0.001 DBMET03592 | DBMET03590 | |
| 0.023 | 0.006 | 0.715 | Purinergic receptor agonist | 0.047 0.003 DBMET03580 0.056 0.003 DBMET00656 0.045 0.003 DBMET03584 0.157 0.001 DBMET03586 0.06 0.002 DBMET03591 0.115 0.001 DBMET03585 0.534 0.001 DBMET03589 0.334 0.001 DBMET03587 0.715 0.001 DBMET03590 0.485 0.001 DBMET03588 0.232 0.001 DBMET03592 | DBMET03590 | |
| 0.022 | 0.008 | 0.038 | Adenosine A3 receptor agonist | 0.033 0.005 DBMET03580 0.028 0.005 DBMET00656 0.019 0.01 DBMET03584 0.022 0.008 DBMET03586 0.038 0.004 DBMET03591 0.02 0.009 DBMET03589 0.019 0.009 DBMET03590 0.018 0.01 DBMET03592 | DBMET03591 | |
| 0.031 | 0.017 | 0.194 | Hypoxanthine phosphoribosyltransferase inhibitor | 0.074 0.005 DBMET03580 0.07 0.006 DBMET00656 0.043 0.011 DBMET00449 0.038 0.013 DBMET03581 0.061 0.007 DBMET03584 0.158 0.001 DBMET03586 0.097 0.003 DBMET03591 0.107 0.002 DBMET03585 0.185 0.001 DBMET03589 0.048 0.009 DB03904 0.029 0.018 DBMET03583 0.124 0.002 DBMET03587 0.194 0.001 DBMET03590 0.131 0.001 DBMET03588 0.12 0.002 DBMET03592 | DBMET03590 | |
| 0.017 | 0.006 | 0.713 | Purinergic P2Y agonist | 0.04 0.003 DBMET03580 0.048 0.003 DBMET00656 0.039 0.003 DBMET03584 0.145 0.001 DBMET03586 0.052 0.002 DBMET03591 0.107 0.001 DBMET03585 0.528 0.001 DBMET03589 0.316 0.001 DBMET03587 0.713 0.001 DBMET03590 0.476 0.001 DBMET03588 0.211 0.001 DBMET03592 | DBMET03590 | |
| 0.018 | 0.007 | 0.029 | Adenosine A2b receptor agonist | 0.029 0.004 DBMET03580 0.022 0.005 DBMET00656 0.015 0.009 DBMET03584 0.018 0.007 DBMET03586 0.027 0.004 DBMET03591 0.016 0.008 DBMET03589 0.016 0.008 DBMET03590 0.013 0.012 DBMET03592 | DBMET03580 | |
| 0.029 | 0.019 | 0.056 | Purinergic P2Y15 antagonist | 0.056 0.003 DBMET03580 0.041 0.006 DBMET00656 0.034 0.011 DBMET03591 0.047 0.004 DB03904 0.032 0.013 DBMET03583 | DBMET03580 | |
| 0.039 | 0.03 | 0.06 | Toll-Like receptor 2 agonist | 0.035 0.034 DBMET03591 0.043 0.027 DBMET03582 0.056 0.021 DB03904 0.06 0.02 DBMET03583 | DBMET03583 | |
| 0.094 | 0.086 | 0.426 | Mucolytic | 0.193 0.015 DBMET03580 0.185 0.017 DBMET00656 0.14 0.038 DBMET03584 0.247 0.007 DBMET03586 0.214 0.011 DBMET03591 0.116 0.058 DBMET03582 0.165 0.025 DBMET03585 0.385 0.003 DBMET03589 0.181 0.019 DB03904 0.147 0.034 DBMET03583 0.248 0.007 DBMET03587 0.426 0.003 DBMET03590 0.269 0.005 DBMET03588 0.186 0.017 DBMET03592 | DBMET03590 | |
| 0.053 | 0.046 | 0.236 | Adenosine A1 receptor antagonist | 0.21 0.01 DBMET03580 0.114 0.021 DBMET00656 0.149 0.016 DBMET03584 0.057 0.042 DBMET03586 0.236 0.009 DBMET03591 0.054 0.045 DB03904 | DBMET03591 | |
| 0.011 | 0.006 | 0.637 | Purinergic P2Y2 agonist | 0.021 0.002 DBMET03580 0.031 0.001 DBMET00656 0.012 0.005 DBMET00449 0.01 0.007 DBMET03581 0.052 0.001 DBMET03584 0.433 0 DBMET03586 0.067 0 DBMET03591 0.362 0 DBMET03585 0.582 0 DBMET03589 0.011 0.007 DB03904 0.508 0 DBMET03587 0.637 0 DBMET03590 0.559 0 DBMET03588 0.324 0 DBMET03592 | DBMET03590 | |
| 0.101 | 0.096 | 0.67 | Aldehyde dehydrogenase inhibitor | 0.11 0.083 DBMET03580 0.103 0.093 DBMET00656 0.529 0.004 DBMET03586 0.183 0.032 DBMET03591 0.22 0.023 DBMET03585 0.67 0.003 DBMET03589 0.171 0.037 DB03904 0.139 0.055 DBMET03583 0.331 0.009 DBMET03587 0.626 0.003 DBMET03590 0.288 0.013 DBMET03588 0.242 0.019 DBMET03592 | DBMET03589 | |
| 0.016 | 0.011 | 0.036 | Adenosine A2 receptor agonist | 0.036 0.004 DBMET03580 0.016 0.011 DBMET00656 0.015 0.014 DBMET03584 0.031 0.005 DBMET03591 0.015 0.012 DB03904 | DBMET03580 | |
| 0.015 | 0.01 | 0.028 | S-adenosyl-L-homocysteine hydrolase inhibitor | 0.028 0.005 DBMET03580 0.02 0.007 DBMET00656 0.018 0.008 DBMET03584 0.016 0.009 DBMET03586 0.024 0.005 DBMET03591 0.015 0.011 DBMET03589 0.014 0.011 DBMET03590 0.018 0.007 DBMET03592 | DBMET03580 | |
| 0.02 | 0.016 | 0.162 | Adenosine kinase inhibitor | 0.09 0.004 DBMET03580 0.042 0.007 DBMET00656 0.052 0.006 DBMET03584 0.098 0.003 DBMET03586 0.068 0.005 DBMET03591 0.083 0.004 DBMET03585 0.143 0.002 DBMET03589 0.117 0.003 DBMET03587 0.162 0.002 DBMET03590 0.132 0.003 DBMET03588 0.079 0.004 DBMET03592 | DBMET03590 | |
| 0.015 | 0.012 | 0.148 | Purinergic P2Y1 agonist | 0.025 0.005 DBMET03580 0.02 0.007 DBMET00656 0.024 0.005 DBMET03584 0.105 0.001 DBMET03586 0.026 0.004 DBMET03591 0.093 0.001 DBMET03585 0.139 0.001 DBMET03589 0.02 0.007 DB03904 0.018 0.008 DBMET03583 0.13 0.001 DBMET03587 0.148 0.001 DBMET03590 0.14 0.001 DBMET03588 0.041 0.002 DBMET03592 | DBMET03590 | |
| 0.018 | 0.016 | 0.127 | Inosine monophosphate dehydrogenase 1 inhibitor | 0.031 0.008 DBMET03580 0.028 0.009 DBMET00656 0.096 0.003 DBMET03586 0.034 0.007 DBMET03591 0.057 0.004 DBMET03585 0.127 0.002 DBMET03589 0.073 0.003 DBMET03587 0.118 0.002 DBMET03590 0.07 0.003 DBMET03588 0.091 0.003 DBMET03592 | DBMET03589 | |
| 0.086 | 0.083 | 0.086 | Interleukin 12 antagonist | |||
| 0.119 | 0.117 | 0.187 | Hemostatic | 0.119 0.117 DBMET03580 0.187 0.039 DB03904 | DB03904 | |
| 0.033 | 0.031 | 0.168 | Antibiotic Aminoglycoside-like | 0.04 0.021 DBMET03580 0.038 0.022 DBMET00656 0.033 0.031 DBMET03581 0.055 0.011 DBMET03584 0.042 0.019 DBMET03586 0.053 0.011 DBMET03591 0.067 0.006 DBMET03582 0.043 0.018 DBMET03585 0.039 0.022 DBMET03589 0.043 0.018 DB03904 0.168 0.001 DBMET03583 0.041 0.02 DBMET03587 0.038 0.023 DBMET03590 0.04 0.021 DBMET03588 0.041 0.02 DBMET03592 | DBMET03583 | |
| 0.116 | 0.115 | 0.242 | Acetylcholine M1 receptor antagonist | 0.166 0.061 DBMET00656 0.118 0.111 DBMET03584 0.154 0.07 DBMET03586 0.143 0.082 DBMET03591 0.129 0.097 DBMET03585 0.222 0.034 DBMET03589 0.133 0.092 DB03904 0.187 0.048 DBMET03587 0.242 0.027 DBMET03590 0.207 0.039 DBMET03588 | DBMET03590 | |
| 0.013 | 0.013 | 0.035 | Adenosine A2a receptor agonist | 0.035 0.004 DBMET03580 0.016 0.01 DBMET00656 0.031 0.005 DBMET03591 0.014 0.011 DB03904 | DBMET03580 | |
| 0.003 | 0.004 | 0.456 | Purinergic P2Y4 agonist | 0.006 0.002 DBMET03580 0.009 0.002 DBMET00656 0.007 0.002 DBMET03584 0.036 0.001 DBMET03586 0.01 0.001 DBMET03591 0.023 0.001 DBMET03585 0.327 0 DBMET03589 0.142 0 DBMET03587 0.456 0 DBMET03590 0.313 0 DBMET03588 0.055 0.001 DBMET03592 | DBMET03590 | |
| 0.147 | 0.149 | 0.377 | Platelet antagonist | 0.237 0.078 DBMET03586 0.159 0.135 DBMET03591 0.169 0.126 DBMET03582 0.185 0.113 DBMET03585 0.31 0.049 DBMET03589 0.278 0.061 DBMET03583 0.254 0.071 DBMET03587 0.324 0.045 DBMET03590 0.27 0.064 DBMET03588 0.377 0.032 DBMET03592 | DBMET03592 | |
| 0.028 | 0.032 | 0.88 | Fumarate hydratase inhibitor | 0.254 0.003 DBMET03580 0.15 0.004 DBMET00656 0.036 0.022 DBMET00449 0.031 0.027 DBMET03581 0.08 0.007 DBMET03584 0.814 0.001 DBMET03586 0.302 0.003 DBMET03591 0.047 0.014 DBMET03582 0.541 0.002 DBMET03585 0.865 0.001 DBMET03589 0.1 0.005 DB03904 0.096 0.005 DBMET03583 0.722 0.001 DBMET03587 0.88 0 DBMET03590 0.754 0.001 DBMET03588 0.426 0.002 DBMET03592 | DBMET03590 | |
| 0.001 | 0.005 | 0.44 | Purinergic P2Y6 agonist | 0.004 0.002 DBMET03580 0.011 0.001 DBMET00656 0.028 0 DBMET03584 0.245 0 DBMET03586 0.04 0 DBMET03591 0.19 0 DBMET03585 0.373 0 DBMET03589 0.311 0 DBMET03587 0.44 0 DBMET03590 0.352 0 DBMET03588 0.169 0 DBMET03592 | DBMET03590 | |
| 0.182 | 0.188 | 0.264 | Transcription factor NF kappa B inhibitor | 0.186 0.184 DBMET00656 0.264 0.117 DB03904 | DB03904 | |
| 0.128 | 0.137 | 0.226 | Angiogenesis stimulant | 0.151 0.122 DBMET03584 0.17 0.11 DBMET03586 0.226 0.081 DBMET03591 0.176 0.107 DBMET03583 | DBMET03591 | |
| 0.075 | 0.086 | 0.753 | NADH dehydrogenase inhibitor | 0.343 0.006 DBMET03580 0.3 0.006 DBMET00656 0.132 0.023 DBMET00449 0.131 0.023 DBMET03581 0.503 0.003 DBMET03584 0.702 0.001 DBMET03586 0.542 0.003 DBMET03591 0.12 0.028 DBMET03582 0.674 0.001 DBMET03585 0.753 0.001 DBMET03589 0.232 0.009 DB03904 0.183 0.012 DBMET03583 0.73 0.001 DBMET03587 0.737 0.001 DBMET03590 0.711 0.001 DBMET03588 0.512 0.003 DBMET03592 | DBMET03589 | |
| 0.041 | 0.055 | 0.278 | Acyl-CoA dehydrogenase inhibitor | 0.122 0.012 DBMET03580 0.079 0.023 DBMET00656 0.06 0.033 DBMET03584 0.252 0.003 DBMET03586 0.123 0.012 DBMET03591 0.1 0.016 DBMET03582 0.193 0.006 DBMET03585 0.278 0.002 DBMET03589 0.187 0.006 DB03904 0.171 0.007 DBMET03583 0.231 0.004 DBMET03587 0.27 0.002 DBMET03590 0.22 0.004 DBMET03588 0.194 0.005 DBMET03592 | DBMET03589 | |
| 0.02 | 0.041 | 0.082 | Sodium/glucose cotransporter inhibitor | 0.028 0.013 DBMET03580 0.043 0.006 DBMET00656 0.043 0.006 DBMET03584 0.024 0.023 DBMET03586 0.082 0.003 DBMET03591 | DBMET03591 | |
| 0.075 | 0.096 | 0.104 | Uric acid excretion stimulant | 0.095 0.058 DBMET03580 0.104 0.049 DBMET03591 | DBMET03591 | |
| 0.012 | 0.034 | 0.019 | O6-alkylguanine-DNA alkyltransferase inhibitor | 0.019 0.009 DBMET03584 0.016 0.015 DBMET03591 | DBMET03584 | |
| 0.072 | 0.095 | 0.101 | Interleukin 5 antagonist | 0.084 0.065 DBMET03580 0.101 0.04 DBMET00449 | DBMET00449 | |
| 0.081 | 0.106 | 0.141 | Phosphodiesterase 6D inhibitor | 0.108 0.038 DBMET00656 0.097 0.058 DBMET00449 0.122 0.024 DBMET03584 0.141 0.012 DBMET03591 0.101 0.05 DB03904 | DBMET03591 | |
| 0.122 | 0.148 | 0.202 | Hepatoprotectant | 0.14 0.121 DBMET03580 0.144 0.116 DBMET00656 0.171 0.088 DBMET03584 0.146 0.114 DBMET03586 0.202 0.063 DBMET03591 0.148 0.112 DBMET03589 0.153 0.107 DBMET03590 0.15 0.11 DBMET03592 | DBMET03591 | |
| 0.076 | 0.108 | 0.165 | Anabolic | 0.095 0.07 DBMET03580 0.122 0.038 DBMET00656 0.089 0.08 DBMET00449 0.147 0.02 DBMET03586 0.105 0.056 DBMET03591 0.128 0.032 DBMET03585 0.16 0.013 DBMET03589 0.138 0.025 DB03904 0.107 0.054 DBMET03583 0.144 0.021 DBMET03587 0.165 0.011 DBMET03590 0.15 0.018 DBMET03588 0.146 0.02 DBMET03592 | DBMET03590 | |
| 0.022 | 0.055 | 0.033 | DNA polymerase III inhibitor | 0.033 0.01 DBMET00449 0.031 0.014 DBMET03581 0.026 0.025 DBMET03588 | DBMET00449 | |
| 0.014 | 0.05 | 0.118 | Protein 30S ribosomal subunit inhibitor | 0.026 0.015 DBMET03582 0.118 0.002 DBMET03583 | DBMET03583 | |
| 0.027 | 0.063 | 0.992 | Phosphorylase inhibitor | 0.08 0.017 DBMET03580 0.259 0.004 DBMET00656 0.057 0.027 DBMET00449 0.413 0.003 DBMET03584 0.92 0.001 DBMET03586 0.634 0.002 DBMET03591 0.747 0.002 DBMET03585 0.985 0.001 DBMET03589 0.882 0.001 DBMET03587 0.989 0.001 DBMET03590 0.914 0.001 DBMET03588 0.992 0.001 DBMET03592 | DBMET03592 | |
| 0.016 | 0.052 | 0.075 | Sodium/glucose cotransporter 2 inhibitor | 0.03 0.013 DBMET03580 0.037 0.009 DBMET00656 0.037 0.009 DBMET03584 0.075 0.004 DBMET03591 | DBMET03591 | |
| 0.177 | 0.216 | 0.333 | Apoptosis antagonist | 0.28 0.1 DBMET00656 0.224 0.153 DBMET03584 0.271 0.108 DBMET03586 0.333 0.065 DBMET03591 0.236 0.142 DBMET03583 | DBMET03591 | |
| 0.023 | 0.063 | 0.664 | RNA-directed RNA polymerase inhibitor | 0.041 0.018 DBMET00656 0.051 0.012 DBMET03584 0.239 0.003 DBMET03586 0.075 0.007 DBMET03591 0.146 0.004 DBMET03585 0.583 0.002 DBMET03589 0.46 0.002 DBMET03587 0.664 0.002 DBMET03590 0.521 0.002 DBMET03588 0.091 0.005 DBMET03592 | DBMET03590 | |
| 0.014 | 0.056 | 0.096 | Arginase inhibitor | 0.039 0.023 DBMET03580 0.09 0.005 DBMET03582 0.096 0.004 DB03904 0.087 0.005 DBMET03583 | DB03904 | |
| 0.07 | 0.114 | 0.511 | Expectorant | 0.18 0.025 DBMET03580 0.162 0.031 DBMET00656 0.113 0.056 DBMET03584 0.289 0.009 DBMET03586 0.207 0.019 DBMET03591 0.097 0.072 DBMET03582 0.169 0.029 DBMET03585 0.477 0.004 DBMET03589 0.156 0.033 DB03904 0.133 0.043 DBMET03583 0.285 0.009 DBMET03587 0.511 0.004 DBMET03590 0.315 0.008 DBMET03588 0.296 0.009 DBMET03592 | DBMET03590 | |
| 0.008 | 0.056 | 0.112 | Purinergic P2Y1 antagonist | 0.085 0.003 DBMET03586 0.089 0.003 DBMET03585 0.093 0.003 DBMET03589 0.099 0.003 DBMET03587 0.104 0.003 DBMET03590 0.112 0.002 DBMET03588 0.067 0.003 DBMET03592 | DBMET03588 | |
| 0.004 | 0.058 | 0.016 | Lysophosphatidic acid receptor 3 agonist | 0.016 0.007 DB03904 0.013 0.01 DBMET03583 | DB03904 | |
| 0.07 | 0.125 | 0.161 | Xanthine oxidase inhibitor | 0.161 0.03 DB03904 | DB03904 | |
| 0.079 | 0.134 | 0.163 | Microtubule formation inhibitor | 0.107 0.078 DBMET03582 0.163 0.031 DB03904 | DB03904 | |
| 0.069 | 0.126 | 0.118 | Topoisomerase II inhibitor | 0.118 0.069 DBMET03580 0.109 0.077 DBMET00656 | DBMET03580 | |
| 0.041 | 0.099 | 0.319 | Purinergic P2X1 antagonist | 0.139 0.008 DBMET03580 0.088 0.021 DBMET00656 0.072 0.03 DBMET03584 0.249 0.002 DBMET03586 0.109 0.014 DBMET03591 0.21 0.003 DBMET03585 0.298 0.002 DBMET03589 0.134 0.009 DB03904 0.061 0.042 DBMET03583 0.247 0.002 DBMET03587 0.319 0.001 DBMET03590 0.262 0.002 DBMET03588 0.16 0.006 DBMET03592 | DBMET03590 | |
| 0.105 | 0.165 | 0.131 | Nitric oxide antagonist | 0.131 0.117 DBMET03591 | DBMET03591 | |
| 0.168 | 0.229 | 0.222 | Caspase 3 stimulant | 0.222 0.14 DBMET03580 0.206 0.16 DBMET03591 | DBMET03580 | |
| 0.006 | 0.068 | 0.052 | Prostacyclin agonist | 0.021 0.008 DBMET03582 0.052 0.004 DBMET03583 | DBMET03583 | |
| 0.011 | 0.073 | 0.02 | Antibiotic Anthracycline-like | 0.02 0.01 DB03904 0.018 0.016 DBMET03583 | DB03904 | |
| 0.175 | 0.237 | 0.38 | Interleukin 2 agonist | 0.219 0.158 DBMET00656 0.325 0.058 DBMET03584 0.356 0.043 DBMET03591 0.243 0.127 DBMET03582 0.38 0.034 DBMET03583 | DBMET03583 | |
| 0.038 | 0.1 | 0.059 | Glucosylceramidase inhibitor | 0.051 0.045 DBMET03581 0.059 0.032 DBMET03591 0.053 0.042 DB03904 | DBMET03591 | |
| 0.103 | 0.169 | 0.191 | Platelet adhesion inhibitor | 0.189 0.077 DBMET03586 0.189 0.077 DBMET03591 0.191 0.076 DBMET03589 0.164 0.093 DBMET03590 | DBMET03589 | |
| 0.012 | 0.08 | 0.277 | Thymidine kinase (Herpes simplex virus 2) inhibitor | 0.025 0.008 DBMET03580 0.047 0.003 DBMET00656 0.028 0.005 DBMET00449 0.039 0.003 DBMET03581 0.277 0.001 DBMET03584 0.022 0.01 DBMET03586 0.084 0.002 DBMET03591 0.04 0.003 DBMET03585 0.022 0.011 DB03904 0.03 0.004 DBMET03587 0.027 0.005 DBMET03588 | DBMET03584 | |
| 0.012 | 0.085 | 0.669 | HCV NS5B polymerase inhibitor | 0.036 0.017 DBMET03580 0.041 0.014 DBMET00656 0.05 0.01 DBMET03584 0.329 0.003 DBMET03586 0.09 0.005 DBMET03591 0.18 0.004 DBMET03585 0.601 0.002 DBMET03589 0.446 0.002 DBMET03587 0.669 0.002 DBMET03590 0.513 0.002 DBMET03588 0.093 0.005 DBMET03592 | DBMET03590 | |
| 0.03 | 0.108 | 0.57 | Biliverdin reductase inhibitor | 0.216 0.005 DBMET03580 0.249 0.004 DBMET00656 0.126 0.013 DBMET00449 0.106 0.017 DBMET03581 0.133 0.012 DBMET03584 0.55 0.001 DBMET03586 0.297 0.003 DBMET03591 0.104 0.017 DBMET03582 0.394 0.002 DBMET03585 0.57 0.001 DBMET03589 0.235 0.004 DB03904 0.185 0.007 DBMET03583 0.418 0.002 DBMET03587 0.55 0.001 DBMET03590 0.394 0.002 DBMET03588 0.381 0.002 DBMET03592 | DBMET03589 | |
| 0.013 | 0.091 | 0.03 | Lysophosphatidic acid receptor 1 agonist | 0.028 0.013 DB03904 0.03 0.011 DBMET03583 | DBMET03583 | |
| 0.084 | 0.166 | 0.19 | Protein kinase stimulant | 0.115 0.098 DBMET00656 0.163 0.059 DBMET03586 0.177 0.051 DBMET03591 0.19 0.045 DB03904 0.12 0.093 DBMET03583 | DB03904 | |
| 0.029 | 0.115 | 0.079 | Alpha-mannosidase inhibitor | 0.065 0.021 DBMET03584 0.077 0.012 DBMET03591 0.056 0.033 DBMET03582 0.079 0.012 DB03904 0.077 0.013 DBMET03583 | DB03904 | |
| 0.043 | 0.131 | 0.074 | Lipocortins synthesis agonist | 0.074 0.017 DBMET03581 0.06 0.035 DBMET03583 | DBMET03581 | |
| 0.011 | 0.103 | 0.036 | Methylmalonyl-CoA mutase inhibitor | 0.02 0.009 DBMET03580 0.017 0.016 DBMET00656 0.031 0.002 DBMET03586 0.02 0.008 DBMET03591 0.017 0.016 DBMET03582 0.025 0.004 DBMET03585 0.036 0.002 DBMET03589 0.021 0.007 DB03904 0.021 0.008 DBMET03583 0.028 0.003 DBMET03587 0.034 0.002 DBMET03590 0.027 0.003 DBMET03588 0.026 0.003 DBMET03592 | DBMET03589 | |
| 0.103 | 0.198 | 0.288 | Anticonvulsant | 0.22 0.07 DBMET00656 0.245 0.059 DBMET00449 0.15 0.129 DBMET03586 0.288 0.044 DBMET03591 0.201 0.082 DB03904 | DBMET03591 | |
| 0.063 | 0.161 | 0.1 | Hematopoietic | 0.1 0.036 DBMET03586 0.097 0.039 DBMET03585 0.079 0.076 DBMET03589 0.082 0.066 DBMET03583 0.08 0.072 DBMET03592 | DBMET03586 | |
| 0.017 | 0.121 | 0.088 | Guanylate cyclase inhibitor | 0.062 0.01 DBMET03580 0.04 0.033 DBMET00656 0.062 0.01 DBMET03584 0.081 0.003 DBMET03586 0.062 0.01 DBMET03591 0.081 0.003 DBMET03585 0.087 0.002 DBMET03589 0.057 0.014 DB03904 0.04 0.033 DBMET03583 0.086 0.002 DBMET03587 0.088 0.002 DBMET03590 0.088 0.002 DBMET03588 0.075 0.004 DBMET03592 | DBMET03588 | |
| 0.019 | 0.124 | 0.073 | Mannosidase inhibitor | 0.053 0.022 DBMET03584 0.068 0.013 DBMET03591 0.043 0.035 DBMET03582 0.069 0.012 DB03904 0.073 0.01 DBMET03583 | DBMET03583 | |
| 0.017 | 0.126 | 0.063 | Geranyltranstransferase inhibitor | 0.053 0.019 DBMET03589 0.063 0.012 DB03904 0.044 0.03 DBMET03583 0.046 0.027 DBMET03590 | DB03904 | |
| 0.088 | 0.2 | 0.22 | Insulin secretagoues | 0.15 0.074 DBMET03586 0.117 0.116 DBMET03591 0.206 0.033 DBMET03589 0.131 0.096 DBMET03587 0.22 0.027 DBMET03590 0.146 0.078 DBMET03588 | DBMET03590 | |
| 0.115 | 0.226 | 0.176 | Ca2+-transporting ATPase inhibitor | 0.131 0.115 DBMET03580 0.136 0.091 DBMET00656 0.139 0.076 DBMET00449 0.134 0.101 DBMET03581 0.133 0.103 DBMET03582 0.176 0.009 DB03904 0.158 0.026 DBMET03583 | DB03904 | |
| 0.021 | 0.14 | 0.046 | Neuraminidase (Influenza A) inhibitor | 0.046 0.031 DB03904 | DB03904 | |
| 0.023 | 0.149 | 0.282 | Purinergic P2X2 antagonist | 0.123 0.019 DBMET03580 0.217 0.004 DBMET03586 0.192 0.005 DBMET03585 0.262 0.003 DBMET03589 0.239 0.003 DBMET03587 0.282 0.002 DBMET03590 0.259 0.003 DBMET03588 0.205 0.004 DBMET03592 | DBMET03590 | |
| 0.021 | 0.149 | 0.054 | Lysophosphatidic acid 3 receptor antagonist | 0.054 0.029 DB03904 0.05 0.036 DBMET03583 | DB03904 | |
| 0.013 | 0.141 | 0.025 | Vitamin D receptor antagonist | 0.025 0.01 DBMET03592 | DBMET03592 | |
| 0.022 | 0.15 | 0.079 | Calcium-independent phospholipase A2 inhibitor | 0.063 0.003 DBMET03582 0.079 0.002 DBMET03583 | DBMET03583 | |
| 0.043 | 0.173 | 0.298 | Alcohol dehydrogenase inhibitor | 0.103 0.049 DBMET03580 0.116 0.038 DBMET00656 0.11 0.042 DBMET00449 0.251 0.008 DBMET03586 0.115 0.038 DBMET03591 0.106 0.046 DBMET03585 0.298 0.005 DBMET03589 0.118 0.036 DB03904 0.112 0.041 DBMET03583 0.123 0.032 DBMET03587 0.253 0.007 DBMET03590 0.107 0.045 DBMET03588 0.154 0.019 DBMET03592 | DBMET03589 | |
| 0.015 | 0.147 | 0.056 | Adenosine A2b receptor antagonist | 0.053 0.031 DBMET00449 0.056 0.027 DBMET03591 | DBMET03591 | |
| 0.004 | 0.137 | 0.027 | Calcium-dependent phospholipase A2 inhibitor | 0.014 0.007 DBMET03582 0.027 0.004 DBMET03583 | DBMET03583 | |
| 0.007 | 0.145 | 0.015 | DNA polymerase III polC-type inhibitor | 0.015 0.006 DBMET00449 0.013 0.01 DBMET03581 | DBMET00449 | |
| 0.055 | 0.194 | 0.227 | AMP-activated protein kinase stimulant | 0.15 0.029 DBMET00656 0.161 0.022 DBMET03584 0.164 0.02 DBMET03586 0.227 0.008 DBMET03591 0.117 0.052 DBMET03585 0.096 0.076 DB03904 | DBMET03591 | |
| 0.082 | 0.221 | 0.38 | NOS3 expression enhancer | 0.168 0.058 DBMET03580 0.211 0.037 DBMET00656 0.195 0.043 DBMET03581 0.38 0.009 DBMET03584 0.268 0.023 DBMET03591 0.161 0.063 DBMET03585 0.128 0.1 DBMET03587 0.12 0.116 DBMET03588 | DBMET03584 | |
| 0.053 | 0.195 | 0.12 | Lanosterol 14 alpha demethylase inhibitor | 0.12 0.031 DB03904 0.089 0.074 DBMET03583 | DB03904 | |
| 0.059 | 0.202 | 0.133 | Toll-Like receptor 4 antagonist | 0.133 0.033 DBMET03586 0.118 0.046 DBMET03585 0.115 0.049 DBMET03589 0.1 0.07 DBMET03587 0.109 0.057 DBMET03590 0.094 0.08 DBMET03588 0.133 0.032 DBMET03592 | DBMET03592 | |
| 0.004 | 0.15 | 0.025 | Purine nucleoside phosphorylase inhibitor | 0.019 0.004 DBMET03586 0.015 0.005 DBMET03591 0.012 0.008 DBMET03585 0.025 0.003 DBMET03589 0.015 0.005 DBMET03587 0.022 0.003 DBMET03590 0.013 0.006 DBMET03588 0.014 0.005 DBMET03592 | DBMET03589 | |
| 0.053 | 0.201 | 0.264 | Amylase inhibitor | 0.138 0.07 DBMET03580 0.204 0.043 DBMET00656 0.153 0.062 DBMET03581 0.116 0.084 DBMET03584 0.264 0.024 DBMET03591 0.138 0.07 DB03904 0.149 0.064 DBMET03583 | DBMET03591 | |
| 0.023 | 0.178 | 0.108 | Glucose-6-phosphate isomerase inhibitor | 0.049 0.03 DBMET03584 0.108 0.004 DBMET03586 0.06 0.018 DBMET03591 0.059 0.019 DBMET03582 0.088 0.007 DBMET03585 0.074 0.011 DBMET03589 0.1 0.005 DB03904 0.081 0.009 DBMET03583 0.061 0.018 DBMET03587 0.069 0.013 DBMET03590 0.056 0.022 DBMET03588 0.048 0.033 DBMET03592 | DBMET03586 | |
| 0.035 | 0.194 | 0.12 | S-adenosyl-L-methionine decarboxylase inhibitor | 0.111 0.008 DBMET03580 0.085 0.029 DBMET00656 0.069 0.061 DBMET00449 0.07 0.059 DBMET03591 0.12 0.006 DB03904 0.086 0.028 DBMET03583 | DB03904 | |
| 0.024 | 0.195 | 0.059 | Neuraminidase (influenza) inhibitor | 0.059 0.055 DBMET03583 | DBMET03583 | |
| 0.011 | 0.187 | 0.259 | Inosine monophosphate dehydrogenase inhibitor | 0.228 0.003 DBMET03586 0.048 0.016 DBMET03591 0.065 0.009 DBMET03585 0.259 0.003 DBMET03589 0.033 0.029 DB03904 0.08 0.007 DBMET03587 0.22 0.003 DBMET03590 0.062 0.01 DBMET03588 0.154 0.004 DBMET03592 | DBMET03589 | |
| 0.021 | 0.198 | 0.129 | 3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor | 0.087 0.021 DBMET03586 0.056 0.044 DBMET03585 0.1 0.017 DBMET03589 0.129 0.01 DB03904 0.064 0.036 DBMET03587 0.085 0.022 DBMET03590 0.054 0.046 DBMET03588 | DB03904 | |
| 0.004 | 0.186 | 0.123 | Inosine monophosphate dehydrogenase 2 inhibitor | 0.106 0.003 DBMET03586 0.024 0.01 DBMET03585 0.123 0.003 DBMET03589 0.031 0.007 DBMET03587 0.104 0.003 DBMET03590 0.023 0.011 DBMET03588 | DBMET03589 | |
| 0.015 | 0.198 | 0.044 | Toll-Like receptor 4 agonist | 0.044 0.004 DBMET03586 0.041 0.005 DBMET03585 0.036 0.006 DBMET03589 0.034 0.007 DBMET03587 0.035 0.007 DBMET03590 0.033 0.008 DBMET03588 0.04 0.005 DBMET03592 | DBMET03586 | |
| 0.082 | 0.266 | 0.18 | Spasmolytic | 0.18 0.137 DBMET03583 | DBMET03583 | |
| 0.015 | 0.199 | 0.032 | Hedgehog signaling activator | 0.032 0.009 DB03904 | DB03904 | |
| 0.016 | 0.202 | 0.109 | HIV-1 integrase (Strand Transfer) inhibitor | 0.079 0.031 DBMET03586 0.109 0.019 DBMET03585 0.063 0.04 DBMET03587 0.056 0.044 DBMET03588 | DBMET03585 | |
| 0.024 | 0.21 | 0.108 | Na+ K+ transporting ATPase inhibitor | 0.108 0.024 DB03904 0.103 0.029 DBMET03583 | DB03904 | |
| 0.016 | 0.206 | 0.054 | Acetyl-CoA transferase 1 inhibitor | 0.054 0.013 DB03904 | DB03904 | |
| 0.026 | 0.217 | 0.092 | DNA gyrase inhibitor | 0.092 0.021 DBMET03581 0.066 0.041 DBMET03582 0.057 0.053 DB03904 | DBMET03581 | |
| 0.01 | 0.204 | 0.037 | Bombesin 1 receptor antagonist | 0.037 0.026 DB03904 | DB03904 | |
| 0.021 | 0.219 | 0.053 | HCV NS3/NS4A protease inhibitor | 0.053 0.028 DB03904 | DB03904 | |
| 0.081 | 0.28 | 0.166 | Interferon gamma antagonist | 0.128 0.115 DBMET00656 0.13 0.111 DBMET03581 0.126 0.12 DBMET03584 0.14 0.092 DBMET03591 0.166 0.061 DB03904 0.145 0.084 DBMET03583 | DB03904 | |
| 0.064 | 0.268 | 0.133 | Factor V inhibitor | 0.1 0.069 DBMET03582 0.133 0.028 DB03904 0.1 0.069 DBMET03583 | DB03904 | |
| 0.115 | 0.319 | 0.904 | DNA directed DNA polymerase inhibitor | 0.406 0.113 DBMET03580 0.322 0.151 DBMET00656 0.502 0.081 DBMET03584 0.561 0.066 DBMET03586 0.36 0.133 DBMET03591 0.686 0.037 DBMET03585 0.778 0.023 DBMET03589 0.867 0.011 DBMET03587 0.825 0.016 DBMET03590 0.904 0.007 DBMET03588 0.304 0.159 DBMET03592 | DBMET03588 | |
| 0.064 | 0.272 | 0.434 | Anesthetic general | 0.19 0.08 DBMET00449 0.141 0.124 DBMET03581 0.193 0.078 DBMET03586 0.302 0.032 DBMET03582 0.163 0.101 DBMET03585 0.434 0.013 DB03904 0.206 0.071 DBMET03583 | DB03904 | |
| 0.017 | 0.225 | 0.058 | Acetyl-CoA transferase inhibitor | 0.058 0.032 DB03904 | DB03904 | |
| 0.006 | 0.218 | 0.042 | HMG CoA reductase inhibitor | 0.042 0.013 DBMET03583 | DBMET03583 | |
| 0.031 | 0.244 | 0.261 | Ornithine decarboxylase inhibitor | 0.141 0.014 DBMET03582 0.111 0.033 DB03904 0.261 0.004 DBMET03583 | DBMET03583 | |
| 0.009 | 0.228 | 0.051 | Acid ceramidase inhibitor | 0.051 0.003 DBMET00449 0.026 0.015 DBMET03581 0.03 0.009 DB03904 | DBMET00449 | |
| 0.016 | 0.236 | 0.197 | AICAR transformylase inhibitor | 0.067 0.011 DBMET03580 0.066 0.011 DBMET00656 0.052 0.02 DBMET00449 0.054 0.018 DBMET03581 0.05 0.023 DBMET03584 0.197 0.002 DBMET03586 0.097 0.005 DBMET03591 0.04 0.039 DBMET03582 0.12 0.004 DBMET03585 0.136 0.003 DBMET03589 0.05 0.022 DB03904 0.057 0.016 DBMET03583 0.069 0.01 DBMET03587 0.123 0.004 DBMET03590 0.062 0.013 DBMET03588 0.054 0.019 DBMET03592 | DBMET03586 | |
| 0.026 | 0.246 | 0.131 | Antiviral (Hepatitis D) | 0.062 0.02 DBMET03586 0.061 0.021 DBMET03585 0.113 0.004 DBMET03589 0.11 0.004 DBMET03587 0.131 0.004 DBMET03590 0.127 0.004 DBMET03588 0.085 0.007 DBMET03592 | DBMET03590 | |
| 0.068 | 0.29 | 0.179 | Hypolipemic | 0.179 0.11 DBMET03582 | DBMET03582 | |
| 0.056 | 0.281 | 0.182 | Interleukin 8 antagonist | 0.159 0.028 DBMET00656 0.116 0.067 DBMET00449 0.182 0.018 DBMET03584 0.148 0.035 DB03904 | DBMET03584 | |
| 0.085 | 0.311 | 0.209 | ATPase inhibitor | 0.136 0.128 DBMET00449 0.209 0.03 DB03904 | DB03904 | |
| 0.104 | 0.339 | 0.61 | Heat shock protein 70 antagonist | 0.16 0.028 DBMET03580 0.155 0.035 DBMET00656 0.311 0.003 DBMET03586 0.167 0.02 DBMET03591 0.178 0.013 DBMET03585 0.536 0.002 DBMET03589 0.155 0.036 DB03904 0.141 0.071 DBMET03583 0.27 0.004 DBMET03587 0.61 0.002 DBMET03590 0.309 0.003 DBMET03588 0.187 0.009 DBMET03592 | DBMET03590 | |
| 0.008 | 0.244 | 0.033 | Vanilloid 2 agonist | 0.033 0.007 DB03904 0.025 0.019 DBMET03583 | DB03904 | |
| 0.013 | 0.255 | 0.027 | Glucosylceramidase stimulant | 0.027 0.022 DB03904 | DB03904 | |
| 0.033 | 0.276 | 0.117 | Sphingomyelinase inhibitor | 0.117 0.044 DB03904 | DB03904 | |
| 0.042 | 0.288 | 0.266 | Psychostimulant | 0.266 0.053 DBMET03586 0.199 0.08 DBMET03585 0.229 0.066 DBMET03589 0.252 0.058 DB03904 0.172 0.098 DBMET03587 0.183 0.09 DBMET03590 0.136 0.129 DBMET03588 | DBMET03586 | |
| 0.015 | 0.264 | 0.377 | Purinergic P2 antagonist | 0.273 0.005 DBMET03586 0.237 0.005 DBMET03585 0.344 0.004 DBMET03589 0.31 0.004 DBMET03587 0.377 0.004 DBMET03590 0.343 0.004 DBMET03588 0.254 0.005 DBMET03592 | DBMET03590 | |
| 0.014 | 0.267 | 0.105 | HIV-1 integrase (3'-Processing) inhibitor | 0.071 0.038 DBMET03586 0.105 0.024 DBMET03585 0.06 0.047 DBMET03587 0.056 0.052 DBMET03588 | DBMET03585 | |
| 0.067 | 0.324 | 0.269 | Growth hormone agonist | 0.128 0.11 DBMET00449 0.126 0.111 DBMET03581 0.123 0.116 DBMET03582 0.181 0.067 DB03904 0.269 0.039 DBMET03583 | DBMET03583 | |
| 0.015 | 0.273 | 0.028 | DNA topoisomerase IV inhibitor | 0.028 0.026 DBMET03581 | DBMET03581 | |
| 0.059 | 0.317 | 0.614 | Antimitotic | 0.168 0.105 DBMET00656 0.614 0.007 DBMET00449 0.306 0.042 DBMET03586 0.249 0.06 DBMET03585 0.23 0.068 DBMET03583 | DBMET00449 | |
| 0 | 0.267 | 0.016 | Mannitol 2-dehydrogenase inhibitor | 0.016 0.003 DBMET03586 0.015 0.003 DBMET03585 0.009 0.005 DBMET03589 0.008 0.006 DBMET03587 0.009 0.005 DBMET03590 0.008 0.006 DBMET03588 | DBMET03586 | |
| 0.018 | 0.285 | 0.075 | Sphingosine kinase 2 inhibitor | 0.075 0.018 DB03904 | DB03904 | |
| 0.131 | 0.4 | 0.566 | Cyclophilin D inhibitor | 0.371 0.108 DBMET03591 0.409 0.086 DBMET03582 0.566 0.034 DBMET03583 | DBMET03583 | |
| 0.021 | 0.293 | 0.083 | Autotaxin inhibitor | 0.083 0.017 DBMET03586 0.064 0.025 DBMET03585 | DBMET03586 | |
| 0.057 | 0.33 | 0.697 | Hexokinase inhibitor | 0.271 0.014 DBMET03580 0.206 0.032 DBMET00656 0.201 0.035 DBMET03584 0.575 0.003 DBMET03586 0.353 0.006 DBMET03591 0.394 0.004 DBMET03585 0.669 0.002 DBMET03589 0.149 0.079 DB03904 0.479 0.003 DBMET03587 0.697 0.002 DBMET03590 0.516 0.003 DBMET03588 0.428 0.004 DBMET03592 | DBMET03590 | |
| 0.039 | 0.315 | 0.511 | Alpha-N-acetylglucosaminidase inhibitor | 0.143 0.059 DBMET00656 0.196 0.035 DBMET00449 0.21 0.031 DBMET03581 0.26 0.021 DBMET03584 0.35 0.012 DBMET03591 0.33 0.013 DBMET03582 0.511 0.005 DB03904 0.485 0.005 DBMET03583 | DB03904 | |
| 0.034 | 0.317 | 0.311 | Phosphodiesterase I inhibitor | 0.181 0.013 DBMET03586 0.091 0.057 DBMET03585 0.284 0.005 DBMET03589 0.127 0.024 DB03904 0.136 0.021 DBMET03587 0.311 0.004 DBMET03590 0.159 0.015 DBMET03588 0.112 0.032 DBMET03592 | DBMET03590 | |
| 0.004 | 0.288 | 0.027 | Acetylcholine M4 receptor agonist | 0.027 0.025 DB03904 | DB03904 | |
| 0.006 | 0.298 | 0.041 | Prostaglandin F2 alpha agonist | 0.041 0.005 DBMET03583 | DBMET03583 | |
| 0.003 | 0.296 | 0.024 | Telomerase stimulant | 0.024 0.004 DB03904 0.017 0.011 DBMET03583 | DB03904 | |
| 0.023 | 0.316 | 0.128 | Glycine receptor antagonist | 0.074 0.067 DBMET00656 0.08 0.057 DBMET00449 0.121 0.017 DBMET03581 0.086 0.048 DBMET03582 0.128 0.014 DB03904 0.089 0.044 DBMET03583 | DB03904 | |
| 0.014 | 0.309 | 0.304 | Catalase inhibitor | 0.075 0.051 DBMET00449 0.187 0.018 DBMET03582 0.304 0.006 DB03904 0.175 0.02 DBMET03583 | DB03904 | |
| 0.005 | 0.301 | 0.052 | Acetylcholine M1 receptor agonist | 0.052 0.025 DBMET03581 | DBMET03581 | |
| 0.075 | 0.38 | 0.192 | Hypoglycemic | 0.177 0.137 DBMET03591 0.163 0.158 DBMET03582 0.192 0.12 DBMET03583 | DBMET03583 | |
| 0.008 | 0.314 | 0.035 | Integrin alpha2beta1 antagonist | 0.033 0.01 DBMET00656 0.029 0.014 DBMET00449 0.035 0.008 DBMET03591 0.026 0.019 DBMET03582 0.031 0.011 DB03904 | DBMET03591 | |
| 0.049 | 0.359 | 0.128 | Glutamate release inhibitor | 0.128 0.017 DB03904 0.111 0.029 DBMET03583 | DB03904 | |
| 0.034 | 0.345 | 0.189 | Thioredoxin inhibitor | 0.085 0.071 DBMET00656 0.129 0.025 DBMET00449 0.189 0.009 DBMET03584 0.125 0.028 DBMET03591 0.104 0.043 DBMET03585 0.087 0.067 DBMET03587 0.082 0.077 DBMET03588 | DBMET03584 | |
| 0.018 | 0.334 | 0.059 | Heparanase inhibitor | 0.059 0.024 DBMET03586 0.054 0.035 DBMET03591 0.049 0.048 DBMET03585 0.056 0.03 DB03904 | DBMET03586 | |
| 0.016 | 0.334 | 0.11 | CXC chemokine 4 receptor antagonist | 0.11 0.022 DB03904 | DB03904 | |
| 0.028 | 0.351 | 0.132 | Glycine receptor agonist | 0.129 0.01 DB03904 0.132 0.01 DBMET03583 | DBMET03583 | |
| 0.018 | 0.344 | 0.04 | Glucose-6-phosphate dehydrogenase inhibitor | 0.04 0.021 DB03904 | DB03904 | |
| 0.044 | 0.369 | 0.202 | Arachidonic acid antagonist | 0.162 0.075 DBMET03581 0.154 0.084 DBMET03582 0.202 0.031 DB03904 0.2 0.033 DBMET03583 | DB03904 | |
| 0.05 | 0.377 | 0.391 | Interleukin agonist | 0.209 0.113 DBMET03580 0.239 0.087 DBMET00656 0.254 0.076 DBMET03584 0.306 0.045 DBMET03586 0.391 0.02 DBMET03591 0.167 0.151 DBMET03585 0.223 0.1 DBMET03589 0.281 0.058 DB03904 0.291 0.053 DBMET03583 0.192 0.128 DBMET03590 | DBMET03591 | |
| 0.041 | 0.371 | 0.136 | Cyclooxygenase 3 inhibitor | 0.136 0.061 DB03904 0.123 0.074 DBMET03583 | DB03904 | |
| 0.061 | 0.397 | 0.184 | Vanilloid 1 agonist | 0.155 0.034 DBMET03582 0.141 0.049 DB03904 0.184 0.017 DBMET03583 | DBMET03583 | |
| 0.033 | 0.377 | 0.188 | Cathepsin H inhibitor | 0.188 0.026 DB03904 0.121 0.074 DBMET03583 | DB03904 | |
| 0.031 | 0.377 | 0.356 | Triose-phosphate isomerase inhibitor | 0.111 0.038 DBMET00449 0.088 0.063 DBMET03581 0.102 0.045 DBMET03584 0.356 0.004 DBMET03586 0.141 0.023 DBMET03591 0.155 0.019 DBMET03582 0.251 0.007 DBMET03585 0.193 0.012 DBMET03589 0.298 0.005 DB03904 0.248 0.007 DBMET03583 0.136 0.024 DBMET03587 0.171 0.015 DBMET03590 0.122 0.031 DBMET03588 | DBMET03586 | |
| 0.012 | 0.368 | 0.18 | Carbonic anhydrase V inhibitor | 0.087 0.032 DBMET03584 0.18 0.009 DBMET03586 0.109 0.024 DBMET03591 0.072 0.041 DBMET03582 0.161 0.012 DBMET03585 0.074 0.04 DBMET03589 0.096 0.028 DB03904 0.116 0.023 DBMET03583 0.061 0.052 DBMET03587 0.061 0.053 DBMET03590 | DBMET03586 | |
| 0.007 | 0.364 | 0.069 | Acetylcholine muscarinic agonist | 0.069 0.027 DBMET03581 | DBMET03581 | |
| 0.035 | 0.393 | 0.174 | Toll-Like receptor 2 antagonist | 0.129 0.069 DBMET03582 0.174 0.037 DB03904 0.166 0.042 DBMET03583 | DB03904 | |
| 0.002 | 0.363 | 0.036 | N-Acetylated alpha-linked acidic dipeptidase inhibitor | 0.036 0.004 DBMET03582 0.032 0.005 DBMET03583 | DBMET03582 | |
| 0.02 | 0.383 | 0.14 | Histamine N-methyltransferase inhibitor | 0.14 0.018 DB03904 0.089 0.056 DBMET03583 | DB03904 | |
| 0.002 | 0.368 | 0.036 | Carbonic anhydrase VIII inhibitor | 0.036 0.004 DB03904 0.032 0.004 DBMET03583 | DB03904 | |
| 0.002 | 0.368 | 0.036 | Carbonic anhydrase X inhibitor | 0.036 0.004 DB03904 0.032 0.004 DBMET03583 | DB03904 | |
| 0.013 | 0.382 | 0.03 | Vasopressin 1A agonist | 0.03 0.017 DB03904 | DB03904 | |
| 0.009 | 0.381 | 0.064 | Membrane dipeptidase inhibitor | 0.063 0.009 DBMET03582 0.064 0.009 DB03904 0.06 0.01 DBMET03583 | DB03904 | |
| 0.047 | 0.418 | 0.153 | Transcription factor STAT6 inhibitor | 0.13 0.044 DBMET03580 0.12 0.059 DBMET00656 0.153 0.021 DBMET03586 0.115 0.069 DBMET03591 0.114 0.071 DBMET03589 0.13 0.043 DB03904 0.102 0.1 DBMET03590 | DBMET03586 | |
| 0.002 | 0.376 | 0.022 | Thromboxane A2 agonist | 0.022 0.005 DB03904 | DB03904 | |
| 0.035 | 0.413 | 0.17 | Vanilloid agonist | 0.105 0.028 DBMET03582 0.17 0.009 DBMET03583 | DBMET03583 | |
| 0.012 | 0.393 | 0.064 | Sphingosine kinase inhibitor | 0.064 0.033 DB03904 | DB03904 | |
| 0.036 | 0.419 | 0.14 | Photosensitizer | 0.135 0.042 DB03904 0.14 0.038 DBMET03583 | DBMET03583 | |
| 0.047 | 0.435 | 0.09 | Folate antagonist | 0.09 0.088 DBMET03583 | DBMET03583 | |
| 0.028 | 0.417 | 0.093 | Bile acid receptor antagonist | 0.093 0.067 DB03904 | DB03904 | |
| 0.012 | 0.402 | 0.078 | Protein kinase C beta inhibitor | 0.078 0.033 DBMET03584 0.067 0.053 DBMET03591 0.074 0.039 DB03904 | DBMET03584 | |
| 0.028 | 0.423 | 0.111 | MAP kinase 13 inhibitor | 0.111 0.066 DBMET00449 | DBMET00449 | |
| 0.048 | 0.444 | 0.147 | Melanin inhibitor | 0.147 0.086 DB03904 | DB03904 | |
| 0.009 | 0.406 | 0.043 | Integrin alpha2 antagonist | 0.039 0.021 DBMET00656 0.038 0.024 DBMET00449 0.041 0.019 DBMET03591 0.036 0.027 DBMET03582 0.043 0.017 DB03904 | DB03904 | |
| 0.005 | 0.403 | 0.049 | Nicotinic acid receptor 2 agonist | 0.049 0.014 DBMET00449 | DBMET00449 | |
| 0.004 | 0.409 | 0.05 | Integrin alphaVbeta3 antagonist | 0.05 0.005 DBMET03581 | DBMET03581 | |
| 0.025 | 0.429 | 0.175 | Thrombolytic | 0.175 0.065 DBMET03583 | DBMET03583 | |
| 0.015 | 0.422 | 0.998 | Cathepsin B inhibitor | 0.998 0 DB03904 | DB03904 | |
| 0.015 | 0.423 | 0.139 | Prostaglandin F2 alpha antagonist | 0.127 0.005 DBMET03582 0.139 0.005 DBMET03583 | DBMET03583 | |
| 0.005 | 0.413 | 0.112 | Carbonic anhydrase VB inhibitor | 0.087 0.02 DBMET03584 0.066 0.03 DBMET03591 0.083 0.021 DB03904 0.112 0.014 DBMET03583 | DBMET03583 | |
| 0.03 | 0.438 | 0.127 | mTOR complex 2 inhibitor | 0.127 0.014 DB03904 | DB03904 | |
| 0.012 | 0.421 | 0.114 | Carbonic anhydrase VA inhibitor | 0.095 0.027 DBMET03584 0.109 0.021 DBMET03586 0.114 0.02 DBMET03591 0.078 0.038 DBMET03582 0.091 0.029 DBMET03585 0.095 0.027 DB03904 0.11 0.021 DBMET03583 | DBMET03591 | |
| 0.089 | 0.499 | 0.151 | MAP kinase kinase 5 inhibitor | 0.151 0.147 DB03904 | DB03904 | |
| 0.019 | 0.429 | 0.138 | Protein kinase C mu inhibitor | 0.138 0.031 DBMET03584 | DBMET03584 | |
| 0.007 | 0.418 | 0.068 | Glutamate (mGluR1) agonist | 0.068 0.004 DBMET00449 0.043 0.005 DB03904 0.028 0.011 DBMET03583 | DBMET00449 | |
| 0.012 | 0.423 | 0.085 | Phosphodiesterase III inhibitor | 0.08 0.035 DBMET00449 0.085 0.032 DBMET03581 | DBMET03581 | |
| 0.016 | 0.427 | 0.072 | HIV-1 integrase inhibitor | 0.072 0.046 DBMET03585 | DBMET03585 | |
| 0.009 | 0.428 | 0.067 | Aminopeptidase N inhibitor | 0.067 0.021 DB03904 | DB03904 | |
| 0.073 | 0.493 | 0.223 | Sodium/bile acid cotransporter inhibitor | 0.223 0.158 DBMET03583 | DBMET03583 | |
| 0.007 | 0.427 | 0.039 | Tryptase inhibitor | 0.039 0.024 DB03904 | DB03904 | |
| 0.013 | 0.434 | 0.085 | Aminopeptidase microsomal inhibitor | 0.085 0.023 DB03904 | DB03904 | |
| 0.022 | 0.447 | 0.644 | Chelator | 0.251 0.016 DBMET03582 0.644 0.003 DBMET03583 | DBMET03583 | |
| 0.006 | 0.433 | 0.022 | Somatostatin 4 antagonist | 0.022 0.018 DB03904 | DB03904 | |
| 0.01 | 0.437 | 0.093 | Protein kinase C eta inhibitor | 0.093 0.019 DBMET03584 | DBMET03584 | |
| 0.005 | 0.435 | 0.238 | Aldose reductase inhibitor | 0.064 0.03 DBMET00449 0.131 0.013 DBMET03582 0.238 0.005 DBMET03583 | DBMET03583 | |
| 0.019 | 0.453 | 0.083 | Corticotropin releasing factor 2 receptor antagonist | 0.058 0.052 DBMET00449 0.075 0.022 DBMET03589 0.076 0.021 DB03904 0.083 0.015 DBMET03590 | DBMET03590 | |
| 0.008 | 0.45 | 0.051 | Glutamate (mGluR3) agonist | 0.044 0.007 DBMET03582 0.051 0.005 DB03904 0.051 0.005 DBMET03583 | DBMET03583 | |
| 0.007 | 0.452 | 0.056 | Carbonic anhydrase XIV inhibitor | 0.056 0.027 DBMET03583 | DBMET03583 | |
| 0.023 | 0.469 | 0.129 | Glutamate (mGluR6) antagonist | 0.062 0.061 DBMET00449 0.078 0.026 DBMET03582 0.129 0.005 DB03904 0.115 0.006 DBMET03583 | DB03904 | |
| 0.007 | 0.455 | 0.041 | Sphingosine kinase 1 inhibitor | 0.041 0.029 DB03904 | DB03904 | |
| 0.008 | 0.459 | 0.256 | Check point kinase 1 inhibitor | 0.063 0.053 DBMET03581 0.256 0.005 DB03904 | DB03904 | |
| 0.019 | 0.471 | 0.281 | Aminopeptidase B inhibitor | 0.209 0.019 DBMET03582 0.281 0.01 DB03904 0.226 0.016 DBMET03583 | DB03904 | |
| 0.003 | 0.455 | 0.094 | Glutamate (mGluR1a) agonist | 0.028 0.01 DBMET00449 0.021 0.017 DBMET03582 0.094 0.004 DB03904 0.035 0.007 DBMET03583 | DB03904 | |
| 0.004 | 0.458 | 0.027 | Neuraminidase (Influenza B) inhibitor | 0.027 0.006 DB03904 0.02 0.018 DBMET03583 | DB03904 | |
| 0.02 | 0.481 | 0.259 | Keratolytic | 0.116 0.023 DBMET00449 0.088 0.04 DBMET03582 0.259 0.005 DB03904 0.096 0.033 DBMET03583 | DB03904 | |
| 0.014 | 0.474 | 0.067 | Beta 2 adrenoreceptor agonist | 0.067 0.026 DB03904 | DB03904 | |
| 0.026 | 0.487 | 0.119 | Carbonic anhydrase III inhibitor | 0.119 0.045 DB03904 0.113 0.049 DBMET03583 | DB03904 | |
| 0.003 | 0.465 | 0.031 | Prostaglandin agonist | 0.031 0.021 DBMET03583 | DBMET03583 | |
| 0.083 | 0.547 | 0.279 | Nitric-oxide synthase stimulant | 0.209 0.075 DBMET03580 0.211 0.072 DBMET00656 0.272 0.02 DBMET00449 0.193 0.101 DBMET03581 0.172 0.148 DBMET03591 0.185 0.117 DBMET03582 0.279 0.018 DB03904 0.23 0.049 DBMET03583 | DB03904 | |
| 0.006 | 0.476 | 0.042 | Delayed rectifier potassium channel blocker | 0.042 0.019 DB03904 | DB03904 | |
| 0.027 | 0.498 | 0.149 | Nav1.4 sodium channel blocker | 0.092 0.09 DBMET03582 0.149 0.034 DB03904 0.108 0.064 DBMET03583 | DB03904 | |
| 0.009 | 0.481 | 0.044 | MAP3K5 inhibitor | 0.044 0.02 DB03904 | DB03904 | |
| 0.048 | 0.521 | 0.191 | Hypoxia-inducible factor 1 alpha inhibitor | 0.191 0.162 DBMET00656 0.183 0.174 DBMET03591 | DBMET00656 | |
| 0.011 | 0.484 | 0.045 | Nicotinic acid receptor 1 agonist | 0.045 0.023 DBMET00449 | DBMET00449 | |
| 0.055 | 0.533 | 0.414 | Histamine release inhibitor | 0.414 0.068 DB03904 0.262 0.146 DBMET03583 | DB03904 | |
| 0.032 | 0.519 | 0.296 | Succinate dehydrogenase inhibitor | 0.148 0.115 DBMET00449 0.207 0.044 DBMET03582 0.296 0.011 DB03904 0.291 0.012 DBMET03583 | DB03904 | |
| 0.033 | 0.526 | 0.486 | Tumour necrosis factor alpha release inhibitor | 0.486 0.015 DBMET03581 0.205 0.104 DB03904 | DBMET03581 | |
| 0.013 | 0.509 | 0.052 | Glutamate (mGluR8) antagonist | 0.037 0.021 DBMET03582 0.044 0.013 DB03904 0.052 0.008 DBMET03583 | DBMET03583 | |
| 0.002 | 0.498 | 0.018 | Cyclin T1 inhibitor | 0.018 0.012 DB03904 | DB03904 | |
| 0.011 | 0.51 | 0.545 | Purinergic P2X4 antagonist | 0.275 0.003 DBMET03586 0.043 0.037 DBMET03591 0.092 0.005 DBMET03585 0.474 0.002 DBMET03589 0.043 0.038 DB03904 0.179 0.003 DBMET03587 0.545 0.002 DBMET03590 0.217 0.003 DBMET03588 0.058 0.016 DBMET03592 | DBMET03590 | |
| 0.023 | 0.524 | 0.14 | Antibacterial (Helicobacter pylori) | 0.14 0.056 DB03904 | DB03904 | |
| 0.009 | 0.513 | 0.087 | Adenylate cyclase 1 inhibitor | 0.087 0.005 DB03904 | DB03904 | |
| 0.006 | 0.511 | 0.114 | Monophenol monooxygenase inhibitor | 0.114 0.066 DB03904 | DB03904 | |
| 0.012 | 0.517 | 0.998 | Cathepsin D inhibitor | 0.998 0 DB03904 | DB03904 | |
| 0.024 | 0.537 | 0.197 | Interleukin antagonist | 0.197 0.086 DB03904 | DB03904 | |
| 0.005 | 0.52 | 0.917 | Alcohol oxidase inhibitor | 0.068 0.03 DBMET00449 0.351 0.004 DBMET03582 0.917 0.002 DB03904 0.62 0.003 DBMET03583 | DB03904 | |
| 0.017 | 0.533 | 0.063 | Carbonic anhydrase II stimulant | 0.05 0.04 DBMET03582 0.063 0.019 DB03904 0.048 0.045 DBMET03583 | DB03904 | |
| 0.009 | 0.53 | 0.069 | Sphingosine 1-phosphate receptor 3 antagonist | 0.06 0.039 DBMET03582 0.059 0.04 DB03904 0.069 0.027 DBMET03583 | DBMET03583 | |
| 0.075 | 0.596 | 0.453 | 5 Hydroxytryptamine release inhibitor | 0.268 0.203 DBMET00449 0.453 0.05 DB03904 0.388 0.086 DBMET03583 | DB03904 | |
| 0.003 | 0.526 | 0.024 | 5 Hydroxytryptamine 4 agonist | 0.024 0.019 DB03904 | DB03904 | |
| 0.004 | 0.527 | 0.038 | Growth hormone releasing factor agonist | 0.038 0.019 DB03904 | DB03904 | |
| 0.005 | 0.529 | 0.051 | Purinergic P2X3 antagonist | 0.041 0.016 DBMET03589 0.051 0.011 DBMET03590 0.037 0.02 DBMET03588 | DBMET03590 | |
| 0.014 | 0.546 | 0.221 | Cystathionine beta-synthase inhibitor | 0.102 0.074 DBMET00449 0.221 0.02 DB03904 0.149 0.041 DBMET03583 | DB03904 | |
| 0.003 | 0.536 | 0.066 | Epoxide hydrolase 2 inhibitor | 0.034 0.012 DBMET03582 0.066 0.005 DB03904 | DB03904 | |
| 0.01 | 0.543 | 0.081 | Kainate receptor agonist | 0.041 0.029 DBMET00656 0.078 0.004 DBMET00449 0.049 0.015 DBMET03581 0.05 0.014 DBMET03582 0.081 0.004 DB03904 0.07 0.004 DBMET03583 | DB03904 | |
| 0.013 | 0.548 | 0.164 | Carbonic anhydrase XIII inhibitor | 0.092 0.042 DB03904 0.164 0.019 DBMET03583 | DBMET03583 | |
| 0.003 | 0.541 | 0.021 | Thyroid hormone alpha agonist | 0.021 0.006 DBMET00449 0.017 0.011 DBMET03581 | DBMET00449 | |
| 0.02 | 0.558 | 0.261 | Insulin sensitizer | 0.228 0.049 DBMET03582 0.218 0.057 DB03904 0.261 0.029 DBMET03583 | DBMET03583 | |
| 0.005 | 0.545 | 0.081 | Androgen agonist | 0.081 0.024 DBMET03581 0.058 0.043 DB03904 | DBMET03581 | |
| 0.003 | 0.545 | 0.042 | DNA gyrase subunit B inhibitor | 0.042 0.02 DBMET03581 0.034 0.033 DB03904 | DBMET03581 | |
| 0.042 | 0.584 | 0.168 | MAP kinase 3 inhibitor | 0.145 0.075 DBMET00656 0.168 0.045 DBMET00449 0.135 0.096 DBMET03591 0.144 0.078 DB03904 | DBMET00449 | |
| 0.009 | 0.553 | 0.055 | Leukotriene C antagonist | 0.055 0.043 DB03904 | DB03904 | |
| 0.006 | 0.55 | 0.036 | Growth factor receptor-bound protein 2 antagonist | 0.036 0.022 DBMET03586 0.035 0.023 DBMET03585 0.034 0.028 DBMET03589 0.033 0.028 DBMET03587 0.033 0.029 DBMET03590 0.033 0.03 DBMET03588 | DBMET03586 | |
| 0.014 | 0.561 | 0.095 | Bombesin 1 receptor agonist | 0.095 0.019 DB03904 | DB03904 | |
| 0.007 | 0.555 | 0.185 | NAD(P)H dehydrogenase (quinone) inhibitor | 0.14 0.022 DBMET03586 0.07 0.061 DBMET03585 0.185 0.011 DBMET03589 0.106 0.034 DBMET03587 0.166 0.015 DBMET03590 0.09 0.043 DBMET03588 | DBMET03589 | |
| 0.005 | 0.553 | 0.077 | Xanthine dehydrogenase inhibitor | 0.077 0.026 DB03904 | DB03904 | |
| 0.006 | 0.563 | 0.041 | Somatostatin 1 antagonist | 0.041 0.025 DB03904 | DB03904 | |
| 0.005 | 0.565 | 0.379 | Protein kinase (CaMK, MLCK, PhK, SNF, KIN, NIM1, MAPKAP, POLO, CHK, ULK, RSK-2nd domain) inhibitor | 0.379 0.005 DB03904 | DB03904 | |
| 0.011 | 0.572 | 0.067 | Pregnane X receptor antagonist | 0.062 0.027 DBMET00449 0.067 0.017 DB03904 | DB03904 | |
| 0.004 | 0.571 | 0.077 | Glutamate (mGluR3) antagonist | 0.056 0.01 DB03904 0.077 0.005 DBMET03583 | DBMET03583 | |
| 0.007 | 0.577 | 0.06 | Maillard reaction inhibitor | 0.06 0.035 DB03904 | DB03904 | |
| 0.058 | 0.627 | 0.35 | Calcium channel activator | 0.212 0.196 DBMET00449 0.306 0.086 DBMET03581 0.21 0.198 DBMET03586 0.35 0.05 DB03904 0.323 0.07 DBMET03583 | DB03904 | |
| 0.032 | 0.602 | 0.201 | Angiogenesis inhibitor | 0.201 0.169 DB03904 | DB03904 | |
| 0.016 | 0.588 | 0.063 | Bombesin 3 receptor antagonist | 0.063 0.03 DB03904 | DB03904 | |
| 0.024 | 0.597 | 0.189 | Interleukin 1 antagonist | 0.189 0.038 DBMET03584 | DBMET03584 | |
| 0.005 | 0.585 | 0.091 | Acetylcholine M5 receptor agonist | 0.084 0.031 DBMET00449 0.083 0.032 DBMET03581 0.091 0.026 DB03904 | DB03904 | |
| 0.007 | 0.588 | 0.073 | Proto-oncogene tyrosine-protein kinase c-hck inhibitor | 0.073 0.063 DB03904 | DB03904 | |
| 0.009 | 0.592 | 0.183 | GABA aminotransferase inhibitor | 0.07 0.061 DBMET03581 0.112 0.02 DBMET03582 0.157 0.007 DB03904 0.183 0.005 DBMET03583 | DBMET03583 | |
| 0.007 | 0.59 | 0.054 | Cyclophilin A inhibitor | 0.054 0.006 DB03904 | DB03904 | |
| 0.005 | 0.591 | 0.13 | Amidase inhibitor | 0.13 0.013 DB03904 | DB03904 | |
| 0.022 | 0.61 | 0.157 | Cytokine production inhibitor | 0.157 0.057 DB03904 | DB03904 | |
| 0.01 | 0.6 | 0.209 | Phospholipase A2 inhibitor | 0.146 0.078 DBMET03582 0.142 0.083 DB03904 0.209 0.038 DBMET03583 | DBMET03583 | |
| 0.01 | 0.6 | 0.09 | Protease 3C (Human rhinovirus) inhibitor | 0.064 0.046 DBMET03581 0.09 0.021 DB03904 | DB03904 | |
| 0.006 | 0.597 | 0.048 | Beta 2 adrenoreceptor antagonist | 0.048 0.039 DB03904 | DB03904 | |
| 0.042 | 0.633 | 0.525 | Ca2+/calmodulin-dependent kinase I alpha inhibitor | 0.525 0.004 DB03904 | DB03904 | |
| 0.001 | 0.592 | 0.016 | Carbonic anhydrase XI inhibitor | 0.016 0.005 DB03904 0.012 0.011 DBMET03583 | DB03904 | |
| 0.01 | 0.603 | 0.137 | Phospholipase D inhibitor | 0.111 0.009 DBMET00449 0.137 0.004 DBMET03581 0.069 0.056 DBMET03582 0.077 0.039 DBMET03589 0.102 0.014 DB03904 0.08 0.034 DBMET03583 0.076 0.042 DBMET03587 0.07 0.054 DBMET03590 0.068 0.057 DBMET03588 | DBMET03581 | |
| 0.016 | 0.609 | 0.106 | Carbonic anhydrase VI inhibitor | 0.106 0.036 DB03904 0.085 0.052 DBMET03583 | DB03904 | |
| 0.006 | 0.603 | 0.037 | Acetyl-CoA carboxylase inhibitor | 0.037 0.036 DBMET03582 | DBMET03582 | |
| 0.053 | 0.655 | 0.538 | 5 Hydroxytryptamine release stimulant | 0.199 0.122 DBMET00449 0.538 0.022 DB03904 0.395 0.047 DBMET03583 | DB03904 | |
| 0.032 | 0.639 | 0.193 | CF transmembrane conductance regulator agonist | 0.128 0.124 DBMET00449 0.193 0.026 DB03904 | DB03904 | |
| 0.023 | 0.631 | 0.141 | MAP3K9 inhibitor | 0.141 0.074 DBMET03584 | DBMET03584 | |
| 0.008 | 0.616 | 0.045 | Adenosine uptake inhibitor | 0.045 0.007 DB03904 | DB03904 | |
| 0.002 | 0.612 | 0.022 | Growth hormone release promoting | 0.022 0.013 DB03904 | DB03904 | |
| 0.009 | 0.619 | 0.057 | Heat shock protein 90 beta antagonist | 0.057 0.045 DB03904 | DB03904 | |
| 0.003 | 0.614 | 0.026 | Cholecystokinin B antagonist | 0.026 0.025 DB03904 | DB03904 | |
| 0.022 | 0.635 | 0.109 | Nav1.1 sodium channel blocker | 0.109 0.056 DBMET00449 | DBMET00449 | |
| 0.008 | 0.625 | 0.071 | 3(or 17)beta-hydroxysteroid dehydrogenase inhibitor | 0.071 0.021 DB03904 | DB03904 | |
| 0.011 | 0.63 | 0.305 | Protein kinase C nu inhibitor | 0.305 0.023 DB03904 | DB03904 | |
| 0.002 | 0.623 | 0.049 | Nicotinic acid receptor 2 antagonist | 0.049 0.004 DBMET00449 0.039 0.005 DBMET03581 0.032 0.01 DB03904 | DBMET00449 | |
| 0.004 | 0.627 | 0.059 | Nicotinic acid receptor agonist | 0.059 0.011 DBMET00449 0.034 0.028 DB03904 | DBMET00449 | |
| 0.029 | 0.654 | 0.214 | Neurotrophic factor enhancer | 0.214 0.064 DB03904 | DB03904 | |
| 0.003 | 0.63 | 0.06 | Calcitonin gene-related peptide antagonist | 0.06 0.006 DBMET00449 0.06 0.006 DBMET03581 | DBMET03581 | |
| 0.004 | 0.631 | 0.042 | Somatostatin 2 antagonist | 0.042 0.017 DB03904 | DB03904 | |
| 0.004 | 0.632 | 0.024 | Factor XIII inhibitor | 0.024 0.009 DB03904 | DB03904 | |
| 0.014 | 0.643 | 0.111 | Bone formation stimulant | 0.111 0.094 DBMET03586 | DBMET03586 | |
| 0.012 | 0.642 | 0.184 | Dual specificity tyrosine-phosphorylation regulated kinase 3 inhibitor | 0.184 0.089 DB03904 | DB03904 | |
| 0 | 0.63 | 0.01 | DNA topoisomerase III inhibitor | 0.01 0.004 DBMET00449 0.009 0.004 DBMET03581 0.009 0.004 DB03904 | DBMET00449 | |
| 0.012 | 0.642 | 0.151 | M18 aspartyl aminopeptidase inhibitor | 0.151 0.051 DB03904 | DB03904 | |
| 0.013 | 0.643 | 0.173 | Nav1.6 sodium channel blocker | 0.164 0.04 DBMET00449 0.173 0.033 DBMET03581 0.131 0.08 DB03904 | DBMET03581 | |
| 0.013 | 0.644 | 0.489 | TRKC antagonist | 0.489 0.006 DBMET03581 0.126 0.125 DB03904 | DBMET03581 | |
| 0.005 | 0.637 | 0.047 | Squalene epoxidase inhibitor | 0.047 0.04 DB03904 | DB03904 | |
| 0.003 | 0.636 | 0.053 | Thyroid hormone agonist | 0.031 0.012 DBMET03582 0.053 0.004 DBMET03583 | DBMET03583 | |
| 0.089 | 0.725 | 0.222 | Ca2+/calmodulin-dependent kinase IV inhibitor | 0.222 0.112 DBMET03584 | DBMET03584 | |
| 0.005 | 0.644 | 0.134 | Factor VIIa inhibitor | 0.134 0.009 DB03904 | DB03904 | |
| 0.003 | 0.642 | 0.04 | Angiotensin AT1 receptor antagonist | 0.04 0.032 DB03904 | DB03904 | |
| 0.01 | 0.65 | 0.062 | Beta 3 adrenoreceptor antagonist | 0.062 0.05 DB03904 | DB03904 | |
| 0.008 | 0.649 | 0.04 | CF transmembrane conductance regulator antagonist | 0.04 0.028 DBMET03584 | DBMET03584 | |
| 0.004 | 0.646 | 0.033 | Calcitonin receptor agonist | 0.033 0.024 DB03904 0.033 0.024 DBMET03583 | DBMET03583 | |
| 0.005 | 0.647 | 0.052 | Diacylglycerol O-acyltransferase inhibitor | 0.052 0.033 DB03904 | DB03904 | |
| 0.012 | 0.654 | 0.063 | Topoisomerase II beta inhibitor | 0.063 0.02 DB03904 | DB03904 | |
| 0.004 | 0.647 | 0.08 | Gonadotropin-releasing hormone receptor antagonist | 0.08 0.01 DB03904 | DB03904 | |
| 0.002 | 0.647 | 0.035 | Methionyl aminopeptidase 1 inhibitor | 0.035 0.018 DBMET00449 0.035 0.017 DB03904 | DB03904 | |
| 0.081 | 0.733 | 0.578 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.281 0.24 DBMET00656 0.5 0.034 DBMET00449 0.42 0.084 DBMET03581 0.334 0.169 DBMET03582 0.578 0.01 DB03904 0.343 0.158 DBMET03583 | DB03904 | |
| 0.007 | 0.66 | 0.138 | Toll-Like receptor 7 antagonist | 0.138 0.008 DBMET03581 | DBMET03581 | |
| 0.021 | 0.675 | 0.658 | Peroxidase inhibitor | 0.174 0.067 DBMET00449 0.429 0.017 DBMET03582 0.658 0.004 DB03904 0.419 0.018 DBMET03583 | DB03904 | |
| 0.005 | 0.661 | 0.476 | Aconitate hydratase inhibitor | 0.052 0.035 DBMET00449 0.048 0.043 DBMET03581 0.459 0.002 DBMET03582 0.37 0.002 DB03904 0.476 0.002 DBMET03583 | DBMET03583 | |
| 0.005 | 0.662 | 0.112 | Acetylcholine agonist | 0.112 0.04 DBMET03581 | DBMET03581 | |
| 0.005 | 0.664 | 0.225 | Pim-1 kinase inhibitor | 0.225 0.011 DBMET03581 | DBMET03581 | |
| 0.01 | 0.669 | 0.197 | Sphingosine 1-phosphate receptor 2 antagonist | 0.197 0.008 DBMET03582 0.185 0.013 DB03904 0.18 0.015 DBMET03583 | DBMET03582 | |
| 0.009 | 0.669 | 0.995 | Phosphodiesterase inhibitor | 0.995 0.002 DB03904 | DB03904 | |
| 0.016 | 0.677 | 0.157 | Sphingosine 1-phosphate receptor 4 antagonist | 0.13 0.056 DBMET03582 0.141 0.042 DB03904 0.157 0.028 DBMET03583 | DBMET03583 | |
| 0.002 | 0.663 | 0.036 | Potassium channel small-conductance Ca-activated activator | 0.036 0.017 DB03904 | DB03904 | |
| 0.004 | 0.665 | 0.094 | Epoxide hydrolase inhibitor | 0.094 0.029 DBMET03582 0.085 0.038 DB03904 | DBMET03582 | |
| 0.005 | 0.667 | 0.059 | Dihydroorotase inhibitor | 0.057 0.018 DBMET00449 0.059 0.017 DB03904 | DB03904 | |
| 0.005 | 0.668 | 0.101 | TIE-2 antagonist | 0.101 0.039 DB03904 | DB03904 | |
| 0.016 | 0.682 | 0.099 | MAP kinase kinase 7 inhibitor | 0.099 0.014 DB03904 0.08 0.046 DBMET03583 | DB03904 | |
| 0.013 | 0.678 | 0.069 | CXC chemokine 1 receptor antagonist | 0.062 0.02 DBMET03582 0.05 0.038 DB03904 0.069 0.014 DBMET03583 | DBMET03583 | |
| 0.019 | 0.686 | 0.139 | Histone deacetylase SIRT1 inhibitor | 0.139 0.072 DB03904 | DB03904 | |
| 0.007 | 0.674 | 0.137 | TRKB antagonist | 0.137 0.055 DBMET03581 | DBMET03581 | |
| 0.029 | 0.697 | 0.329 | Gastrin inhibitor | 0.204 0.142 DBMET00449 0.254 0.074 DBMET03582 0.329 0.017 DB03904 0.184 0.173 DBMET03583 | DB03904 | |
| 0.005 | 0.673 | 0.105 | TIE antagonist | 0.105 0.038 DB03904 | DB03904 | |
| 0.025 | 0.694 | 0.098 | Estrogen-related receptor beta agonist | 0.098 0.027 DB03904 0.089 0.043 DBMET03583 | DB03904 | |
| 0.002 | 0.672 | 0.032 | Nicotinic alpha4beta2 receptor agonist | 0.032 0.014 DBMET03581 0.03 0.017 DB03904 | DBMET03581 | |
| 0.008 | 0.679 | 0.117 | Beta amyloid protein antagonist | 0.117 0.071 DB03904 | DB03904 | |
| 0.009 | 0.68 | 0.44 | Pyruvate kinase inhibitor | 0.309 0.046 DBMET03586 0.398 0.021 DBMET03589 0.141 0.124 DB03904 0.186 0.089 DBMET03587 0.44 0.015 DBMET03590 0.223 0.07 DBMET03588 | DBMET03590 | |
| 0.003 | 0.679 | 0.024 | Calcitonin gene-related peptide 1 receptor antagonist | 0.024 0.006 DBMET00449 0.021 0.008 DBMET03581 | DBMET00449 | |
| 0.072 | 0.751 | 0.312 | MAP kinase kinase 3 inhibitor | 0.312 0.005 DB03904 | DB03904 | |
| 0.004 | 0.683 | 0.052 | Raf kinase B inhibitor | 0.052 0.048 DBMET00449 | DBMET00449 | |
| 0.009 | 0.691 | 0.401 | Ferrochelatase inhibitor | 0.254 0.013 DBMET00449 0.183 0.027 DBMET03581 0.247 0.014 DBMET03582 0.401 0.004 DB03904 0.397 0.004 DBMET03583 | DB03904 | |
| 0.014 | 0.696 | 0.164 | Thiol protease inhibitor | 0.164 0.058 DB03904 | DB03904 | |
| 0.01 | 0.691 | 0.113 | Caspase 3 inhibitor | 0.113 0.071 DBMET03583 | DBMET03583 | |
| 0.006 | 0.688 | 0.056 | Potassium channel (ATP-sensitive) activator | 0.056 0.021 DB03904 | DB03904 | |
| 0.007 | 0.692 | 0.047 | Potassium channel Kv1.1 blocker | 0.047 0.015 DB03904 | DB03904 | |
| 0.013 | 0.698 | 0.204 | Somatostatin 1 agonist | 0.072 0.062 DBMET03582 0.204 0.006 DB03904 0.075 0.058 DBMET03583 | DB03904 | |
| 0.009 | 0.695 | 0.2 | Creatine kinase inhibitor | 0.088 0.075 DBMET00449 0.098 0.062 DBMET03582 0.2 0.01 DB03904 0.178 0.015 DBMET03583 | DB03904 | |
| 0.005 | 0.692 | 0.059 | Potassium channel (Inward rectifier) activator | 0.059 0.022 DB03904 | DB03904 | |
| 0.015 | 0.702 | 0.129 | TRPA1 agonist | 0.129 0.049 DB03904 | DB03904 | |
| 0.019 | 0.707 | 0.098 | CDK3/cyclin E inhibitor | 0.098 0.092 DBMET00449 | DBMET00449 | |
| 0.004 | 0.696 | 0.161 | Integrin beta6 antagonist | 0.161 0.001 DBMET03581 0.015 0.008 DBMET03583 | DBMET03581 | |
| 0.057 | 0.749 | 0.279 | MAP kinase kinase 6 inhibitor | 0.279 0.157 DB03904 | DB03904 | |
| 0.005 | 0.699 | 0.061 | Beta adrenoreceptor antagonist | 0.061 0.054 DB03904 | DB03904 | |
| 0.007 | 0.703 | 0.071 | 3-Hydroxyanthranilate 3,4-dioxygenase inhibitor | 0.071 0.004 DB03904 0.055 0.01 DBMET03583 | DB03904 | |
| 0.013 | 0.716 | 0.191 | Ca2+/calmodulin-dependent protein kinase inhibitor | 0.191 0.08 DB03904 | DB03904 | |
| 0.011 | 0.72 | 0.16 | Ca2+/calmodulin-dependent kinase II gamma inhibitor | 0.16 0.082 DB03904 | DB03904 | |
| 0.006 | 0.715 | 0.13 | MAP kinase kinase 1 inhibitor | 0.09 0.071 DBMET00449 0.102 0.054 DBMET03581 0.13 0.027 DB03904 0.085 0.078 DBMET03583 | DB03904 | |
| 0.005 | 0.715 | 0.059 | Carbonic anhydrase I stimulant | 0.043 0.021 DBMET03582 0.059 0.012 DB03904 0.033 0.031 DBMET03583 | DB03904 | |
| 0.005 | 0.716 | 0.181 | CDC-like kinase 2 inhibitor | 0.181 0.077 DB03904 | DB03904 | |
| 0.007 | 0.717 | 0.11 | Phenylethanolamine N methyltransferase inhibitor | 0.11 0.003 DBMET03581 | DBMET03581 | |
| 0 | 0.713 | 0.026 | Glutamate (mGluR6) agonist | 0.011 0.009 DBMET03582 0.022 0.004 DB03904 0.026 0.003 DBMET03583 | DBMET03583 | |
| 0.006 | 0.72 | 0.041 | Thrombin receptor antagonist | 0.041 0.011 DB03904 | DB03904 | |
| 0.007 | 0.721 | 0.095 | p38 MAP kinase inhibitor | 0.095 0.034 DB03904 | DB03904 | |
| 0.006 | 0.72 | 0.112 | Protein kinase C gamma inhibitor | 0.098 0.081 DBMET03584 0.112 0.06 DB03904 | DB03904 | |
| 0 | 0.715 | 0.014 | Thyroid hormone beta agonist | 0.014 0.004 DBMET03583 | DBMET03583 | |
| 0.009 | 0.727 | 0.164 | 5 Hydroxytryptamine 1B agonist | 0.063 0.023 DBMET03582 0.164 0.004 DBMET03583 | DBMET03583 | |
| 0.034 | 0.754 | 0.57 | GABA C receptor rho-3 antagonist | 0.418 0.054 DBMET00449 0.358 0.081 DBMET03581 0.258 0.147 DBMET03582 0.57 0.011 DB03904 0.397 0.063 DBMET03583 | DB03904 | |
| 0.008 | 0.728 | 0.083 | Cathepsin G inhibitor | 0.083 0.041 DB03904 | DB03904 | |
| 0.001 | 0.724 | 0.021 | Alpha 2c adrenoreceptor agonist | 0.021 0.01 DB03904 | DB03904 | |
| 0.01 | 0.735 | 0.185 | Prolactin inhibitor | 0.091 0.065 DBMET03582 0.185 0.012 DB03904 0.099 0.057 DBMET03583 | DB03904 | |
| 0.003 | 0.728 | 0.13 | Pim-3 kinase inhibitor | 0.098 0.048 DBMET00449 0.13 0.026 DBMET03581 0.086 0.065 DB03904 | DBMET03581 | |
| 0.006 | 0.733 | 0.118 | Carbonic anhydrase stimulant | 0.096 0.02 DBMET03582 0.118 0.015 DB03904 0.094 0.02 DBMET03583 | DB03904 | |
| 0.007 | 0.734 | 0.131 | Falcipain 3 inhibitor | 0.131 0.047 DB03904 | DB03904 | |
| 0.005 | 0.735 | 0.357 | Leukotriene synthesis inhibitor | 0.064 0.049 DBMET03582 0.357 0.004 DB03904 | DB03904 | |
| 0.003 | 0.733 | 0.05 | Carboxypeptidase B inhibitor | 0.038 0.015 DBMET03582 0.05 0.007 DB03904 0.039 0.014 DBMET03583 | DB03904 | |
| 0.021 | 0.751 | 0.062 | Prolactin release inhibitor | 0.062 0.044 DB03904 | DB03904 | |
| 0.002 | 0.732 | 0.046 | Dihydropteroate synthase inhibitor | 0.046 0.02 DB03904 | DB03904 | |
| 0.001 | 0.732 | 0.057 | Free fatty acid receptor 1 antagonist | 0.057 0.006 DBMET03583 | DBMET03583 | |
| 0.012 | 0.743 | 0.244 | Dual specificity tyrosine-phosphorylation-regulated kinase 4 inhibitor | 0.244 0.038 DB03904 | DB03904 | |
| 0.004 | 0.735 | 0.028 | Estrogen-related receptor gamma antagonist | 0.028 0.02 DB03904 | DB03904 | |
| 0.013 | 0.744 | 0.151 | Antipruritic | 0.151 0.094 DB03904 | DB03904 | |
| 0.004 | 0.735 | 0.326 | Glutamate decarboxylase inhibitor | 0.199 0.007 DBMET03582 0.326 0.003 DB03904 0.262 0.004 DBMET03583 | DB03904 | |
| 0.015 | 0.751 | 0.141 | EphB2 antagonist | 0.141 0.139 DB03904 | DB03904 | |
| 0.001 | 0.737 | 0.059 | Lysine carboxypeptidase inhibitor | 0.038 0.011 DBMET03582 0.049 0.008 DB03904 0.059 0.006 DBMET03583 | DBMET03583 | |
| 0.013 | 0.749 | 0.088 | Vanilloid 4 agonist | 0.088 0.028 DB03904 | DB03904 | |
| 0.009 | 0.745 | 0.058 | Phosphodiesterase 1A inhibitor | 0.058 0.046 DBMET00449 | DBMET00449 | |
| 0.003 | 0.74 | 0.074 | Glutamate (mGluR group I) agonist | 0.074 0.014 DBMET00449 0.044 0.038 DBMET03581 0.043 0.039 DB03904 | DBMET00449 | |
| 0.001 | 0.74 | 0.019 | Nicotinic acid receptor 1 antagonist | 0.019 0.01 DB03904 | DB03904 | |
| 0.056 | 0.798 | 0.438 | 5 Hydroxytryptamine uptake stimulant | 0.244 0.087 DBMET00449 0.199 0.153 DBMET03581 0.249 0.082 DBMET03582 0.438 0.009 DB03904 0.364 0.022 DBMET03583 | DB03904 | |
| 0.004 | 0.748 | 0.103 | Secretase beta inhibitor | 0.103 0.017 DBMET00449 0.075 0.042 DBMET03581 0.082 0.033 DB03904 | DBMET00449 | |
| 0.004 | 0.75 | 0.262 | Phenylalanine 4-hydroxylase inhibitor | 0.093 0.029 DBMET03582 0.17 0.009 DB03904 0.262 0.005 DBMET03583 | DBMET03583 | |
| 0.016 | 0.762 | 0.069 | Transcription factor RelA inhibitor | 0.069 0.032 DB03904 | DB03904 | |
| 0.001 | 0.747 | 0.046 | Carbonic anhydrase IV inhibitor | 0.044 0.029 DB03904 0.046 0.028 DBMET03583 | DBMET03583 | |
| 0.004 | 0.75 | 0.094 | Cyclin E inhibitor | 0.094 0.027 DB03904 | DB03904 | |
| 0.007 | 0.756 | 0.091 | Cyclin D1 inhibitor | 0.091 0.011 DB03904 | DB03904 | |
| 0.006 | 0.758 | 0.079 | Glutamate (mGluR8) agonist | 0.045 0.016 DBMET03582 0.079 0.004 DB03904 0.075 0.004 DBMET03583 | DB03904 | |
| 0.013 | 0.766 | 0.548 | Aldehyde oxidase inhibitor | 0.292 0.069 DBMET00449 0.248 0.083 DBMET03581 0.15 0.139 DBMET03582 0.548 0.026 DB03904 0.365 0.052 DBMET03583 | DB03904 | |
| 0.007 | 0.761 | 0.282 | GABA C receptor antagonist | 0.126 0.046 DBMET00449 0.102 0.075 DBMET03581 0.138 0.037 DBMET03582 0.276 0.005 DB03904 0.282 0.005 DBMET03583 | DBMET03583 | |
| 0.009 | 0.764 | 0.091 | Glutathione S-transferase inhibitor | 0.091 0.047 DB03904 | DB03904 | |
| 0.008 | 0.763 | 0.043 | Heme oxygenase inhibitor | 0.043 0.03 DB03904 | DB03904 | |
| 0.003 | 0.757 | 0.037 | Dipeptidyl peptidase II inhibitor | 0.037 0.016 DB03904 0.031 0.025 DBMET03583 | DB03904 | |
| 0.008 | 0.764 | 0.129 | Interleukin-1 receptor-associated protein kinase 1 inhibitor | 0.129 0.115 DB03904 | DB03904 | |
| 0.009 | 0.765 | 0.233 | GABA C receptor rho-1 antagonist | 0.107 0.053 DBMET00449 0.09 0.078 DBMET03581 0.119 0.041 DBMET03582 0.233 0.005 DB03904 0.22 0.005 DBMET03583 | DB03904 | |
| 0.001 | 0.757 | 0.031 | Fructose-1,6-bisphosphatase 1 inhibitor | 0.031 0.007 DB03904 | DB03904 | |
| 0.001 | 0.758 | 0.02 | Retinoid X beta receptor antagonist | 0.02 0.016 DBMET03583 | DBMET03583 | |
| 0.002 | 0.759 | 0.019 | Alpha 2b adrenoreceptor agonist | 0.019 0.012 DB03904 | DB03904 | |
| 0 | 0.758 | 0.014 | 1-Deoxy-D-xylulose-5-phosphate reductoisomerase inhibitor | 0.014 0.007 DB03904 | DB03904 | |
| 0.015 | 0.773 | 0.233 | GABA C receptor rho-2 antagonist | 0.166 0.055 DBMET00449 0.135 0.096 DBMET03581 0.233 0.016 DB03904 0.153 0.07 DBMET03583 | DB03904 | |
| 0.005 | 0.764 | 0.099 | Gastric antisecretory | 0.099 0.068 DB03904 | DB03904 | |
| 0.011 | 0.771 | 0.242 | Electrolyte absorption antagonist | 0.096 0.063 DBMET00449 0.194 0.009 DBMET03582 0.242 0.005 DB03904 0.13 0.029 DBMET03583 | DB03904 | |
| 0.011 | 0.771 | 0.143 | Nav1.2 sodium channel blocker | 0.143 0.062 DBMET03581 0.139 0.065 DB03904 | DBMET03581 | |
| 0.005 | 0.766 | 0.16 | Aminopeptidase I inhibitor | 0.118 0.02 DBMET03582 0.146 0.013 DB03904 0.16 0.011 DBMET03583 | DBMET03583 | |
| 0.011 | 0.773 | 0.117 | Exportin-1 inhibitor | 0.066 0.052 DBMET00449 0.083 0.021 DBMET03581 0.069 0.046 DBMET03582 0.117 0.005 DB03904 0.082 0.023 DBMET03583 | DB03904 | |
| 0.003 | 0.765 | 0.071 | TRPA1 antagonist | 0.055 0.05 DBMET00449 0.071 0.031 DBMET03581 | DBMET03581 | |
| 0.006 | 0.772 | 0.367 | GABA B receptor agonist | 0.138 0.005 DBMET03582 0.105 0.013 DB03904 0.367 0.002 DBMET03583 | DBMET03583 | |
| 0.002 | 0.77 | 0.045 | Peptide deformylase inhibitor | 0.045 0.012 DB03904 | DB03904 | |
| 0.003 | 0.771 | 0.096 | Interleukin-1 receptor-associated protein kinase 4 inhibitor | 0.096 0.049 DBMET03581 | DBMET03581 | |
| 0.003 | 0.772 | 0.07 | Sphingosine 1-phosphate receptor 3 agonist | 0.07 0.01 DBMET03586 0.067 0.01 DBMET03585 | DBMET03586 | |
| 0.006 | 0.777 | 0.077 | Ryanodine receptor antagonist | 0.077 0.011 DB03904 | DB03904 | |
| 0.004 | 0.775 | 0.075 | Adrenaline agonist | 0.075 0.065 DB03904 | DB03904 | |
| 0.003 | 0.775 | 0.387 | Histidine decarboxylase inhibitor | 0.201 0.013 DBMET03582 0.387 0.004 DB03904 0.268 0.008 DBMET03583 | DB03904 | |
| 0.01 | 0.783 | 0.057 | Bombesin 2 receptor antagonist | 0.057 0.026 DB03904 0.045 0.043 DBMET03583 | DB03904 | |
| 0.013 | 0.786 | 0.125 | Nav1.3 sodium channel blocker | 0.102 0.095 DBMET00449 0.125 0.069 DBMET03581 | DBMET03581 | |
| 0.01 | 0.783 | 0.19 | Sphingosine 1-phosphate receptor 5 antagonist | 0.19 0.016 DB03904 0.142 0.076 DBMET03583 | DB03904 | |
| 0.006 | 0.779 | 0.072 | Potassium channel (Tandem pore domain) blocker | 0.072 0.058 DB03904 | DB03904 | |
| 0.007 | 0.782 | 0.251 | Mannose-6-phosphate isomerase inhibitor | 0.143 0.071 DBMET00449 0.251 0.012 DBMET03586 0.192 0.035 DBMET03585 0.146 0.068 DBMET03589 0.185 0.039 DB03904 0.126 0.091 DBMET03590 | DBMET03586 | |
| 0.02 | 0.795 | 0.747 | Superoxide dismutase inhibitor | 0.208 0.108 DBMET00449 0.179 0.143 DBMET03581 0.392 0.028 DBMET03582 0.747 0.004 DB03904 0.431 0.022 DBMET03583 | DB03904 | |
| 0.003 | 0.778 | 0.132 | Protein kinase (CK2) inhibitor | 0.125 0.045 DBMET00449 0.132 0.041 DBMET03581 | DBMET03581 | |
| 0.003 | 0.78 | 0.051 | GABA B receptor antagonist | 0.051 0.019 DB03904 0.043 0.029 DBMET03583 | DB03904 | |
| 0 | 0.781 | 0.017 | Aminopeptidase A inhibitor | 0.017 0.014 DB03904 0.017 0.013 DBMET03583 | DBMET03583 | |
| 0.006 | 0.787 | 0.122 | Histamine H2 receptor antagonist | 0.122 0.02 DB03904 | DB03904 | |
| 0.003 | 0.785 | 0.079 | Alpha 2 adrenoreceptor agonist | 0.079 0.024 DB03904 | DB03904 | |
| 0.016 | 0.799 | 0.126 | D-Ala-D-Ala ligase inhibitor | 0.126 0.011 DB03904 0.092 0.04 DBMET03583 | DB03904 | |
| 0.003 | 0.787 | 0.088 | Protein kinase C zeta inhibitor | 0.088 0.07 DB03904 | DB03904 | |
| 0.005 | 0.79 | 0.204 | GABA receptor agonist | 0.204 0.017 DBMET03583 | DBMET03583 | |
| 0.004 | 0.789 | 0.073 | Potassium channel (ATP-sensitive) blocker | 0.073 0.036 DB03904 | DB03904 | |
| 0.006 | 0.792 | 0.055 | Botulinum neurotoxin type A inhibitor | 0.055 0.045 DB03904 | DB03904 | |
| 0.003 | 0.79 | 0.065 | Oxytocin agonist | 0.065 0.013 DB03904 0.04 0.031 DBMET03583 | DB03904 | |
| 0.001 | 0.789 | 0.028 | AMPA 1 receptor antagonist | 0.028 0.021 DB03904 | DB03904 | |
| 0 | 0.79 | 0.007 | Integrin alpha5beta6 antagonist | 0.007 0.005 DB03904 | DB03904 | |
| 0.001 | 0.791 | 0.03 | CXC chemokine 2 receptor antagonist | 0.03 0.014 DB03904 | DB03904 | |
| 0.009 | 0.8 | 0.113 | Proteasome inhibitor | 0.113 0.072 DB03904 | DB03904 | |
| 0.002 | 0.793 | 0.138 | NMDA receptor glycine site agonist | 0.105 0.014 DBMET03582 0.138 0.005 DB03904 0.094 0.019 DBMET03583 | DB03904 | |
| 0.01 | 0.802 | 0.124 | Acetylcholine release stimulant | 0.124 0.042 DB03904 | DB03904 | |
| 0.003 | 0.796 | 0.093 | MAP kinase kinase kinase inhibitor | 0.093 0.073 DB03904 | DB03904 | |
| 0.001 | 0.795 | 0.02 | Glutaminyl-peptide cyclotransferase inhibitor | 0.02 0.019 DB03904 | DB03904 | |
| 0.004 | 0.798 | 0.11 | Glutamate (mGluR7) antagonist | 0.074 0.036 DBMET00449 0.11 0.006 DB03904 0.079 0.029 DBMET03583 | DB03904 | |
| 0.008 | 0.802 | 0.223 | Protein kinase (CK1) gamma 3 inhibitor | 0.223 0.036 DB03904 | DB03904 | |
| 0.003 | 0.798 | 0.058 | Factor VII inhibitor | 0.058 0.01 DB03904 | DB03904 | |
| 0.003 | 0.797 | 0.101 | Histamine H2 receptor agonist | 0.043 0.03 DBMET00449 0.049 0.023 DBMET03582 0.101 0.004 DB03904 | DB03904 | |
| 0.005 | 0.8 | 0.1 | Thrombin inhibitor | 0.1 0.026 DB03904 | DB03904 | |
| 0.002 | 0.798 | 0.047 | Free fatty acid receptor 1 agonist | 0.047 0.005 DBMET03583 | DBMET03583 | |
| 0.005 | 0.803 | 0.495 | 5-Lipoxygenase inhibitor | 0.495 0.004 DB03904 | DB03904 | |
| 0.006 | 0.806 | 0.725 | GABA C receptor agonist | 0.208 0.019 DBMET00449 0.195 0.021 DBMET03581 0.457 0.004 DBMET03582 0.574 0.003 DB03904 0.725 0.002 DBMET03583 | DBMET03583 | |
| 0.003 | 0.804 | 0.069 | Nicotinic alpha4beta2 receptor antagonist | 0.069 0.063 DB03904 | DB03904 | |
| 0.002 | 0.805 | 0.073 | Fibroblast growth factor 3 antagonist | 0.073 0.06 DB03904 | DB03904 | |
| 0.01 | 0.813 | 0.131 | Granulocyte macrophage colony stimulating factor agonist | 0.131 0.01 DB03904 0.091 0.05 DBMET03583 | DB03904 | |
| 0.005 | 0.809 | 0.144 | Protein kinase B beta inhibitor | 0.144 0.009 DB03904 | DB03904 | |
| 0.001 | 0.806 | 0.055 | Diamine oxidase inhibitor | 0.055 0.012 DB03904 0.035 0.029 DBMET03583 | DB03904 | |
| 0.004 | 0.808 | 0.05 | Melatonin receptor 1A agonist | 0.032 0.026 DBMET03582 0.05 0.008 DB03904 | DB03904 | |
| 0.019 | 0.824 | 0.063 | Calcium channel P-type blocker | 0.063 0.045 DB03904 | DB03904 | |
| 0.002 | 0.807 | 0.068 | Vascular adhesion protein 1 inhibitor | 0.043 0.022 DBMET03581 0.047 0.018 DBMET03582 0.068 0.007 DB03904 0.054 0.012 DBMET03583 | DB03904 | |
| 0.003 | 0.809 | 0.091 | Sphingosine 1-phosphate receptor 4 agonist | 0.091 0.03 DB03904 0.076 0.04 DBMET03583 | DB03904 | |
| 0.004 | 0.81 | 0.028 | Baculoviral IAP repeat-containing protein 4 inhibitor | 0.028 0.018 DB03904 | DB03904 | |
| 0.001 | 0.809 | 0.079 | Fructose-1,6-bisphosphatase inhibitor | 0.079 0.008 DB03904 | DB03904 | |
| 0.007 | 0.816 | 0.126 | Dihydroorotate oxidase inhibitor | 0.126 0.004 DBMET00449 0.069 0.018 DBMET03581 0.075 0.013 DB03904 | DBMET00449 | |
| 0.001 | 0.812 | 0.044 | Epoxide hydrolase 1 inhibitor | 0.044 0.008 DB03904 | DB03904 | |
| 0.004 | 0.818 | 0.253 | Calpain 2 inhibitor | 0.253 0.147 DB03904 | DB03904 | |
| 0.004 | 0.82 | 0.177 | Alkaline phosphatase inhibitor | 0.177 0.044 DB03904 | DB03904 | |
| 0.002 | 0.818 | 0.058 | Pim-2 kinase inhibitor | 0.058 0.033 DBMET03581 | DBMET03581 | |
| 0.007 | 0.822 | 0.258 | Protein kinase (CK1) gamma 1 inhibitor | 0.258 0.027 DB03904 | DB03904 | |
| 0.004 | 0.821 | 0.051 | Phosphatidylinositol 3-kinase gamma inhibitor | 0.051 0.043 DB03904 | DB03904 | |
| 0.001 | 0.818 | 0.029 | Kainate receptor 1 antagonist | 0.029 0.01 DB03904 0.023 0.014 DBMET03583 | DB03904 | |
| 0.013 | 0.831 | 0.057 | DNA helicase inhibitor | 0.057 0.033 DBMET03583 | DBMET03583 | |
| 0.005 | 0.825 | 0.191 | Protein kinase (CK1) gamma 2 inhibitor | 0.191 0.035 DB03904 | DB03904 | |
| 0.002 | 0.821 | 0.043 | GABA uptake inhibitor | 0.043 0.022 DB03904 0.041 0.025 DBMET03583 | DB03904 | |
| 0.006 | 0.826 | 0.037 | Erythropoietin receptor agonist | 0.037 0.032 DBMET03582 | DBMET03582 | |
| 0.004 | 0.825 | 0.317 | Diuretic | 0.317 0.02 DB03904 | DB03904 | |
| 0.003 | 0.824 | 0.403 | Porphobilinogen synthase inhibitor | 0.069 0.057 DBMET00449 0.122 0.028 DBMET03582 0.272 0.006 DB03904 0.403 0.004 DBMET03583 | DBMET03583 | |
| 0.008 | 0.83 | 0.177 | DOPA decarboxylase inhibitor | 0.108 0.061 DBMET00449 0.111 0.057 DBMET03582 0.177 0.011 DB03904 0.164 0.015 DBMET03583 | DB03904 | |
| 0.002 | 0.826 | 0.062 | Neutrophil collagenase inhibitor | 0.061 0.049 DB03904 0.062 0.048 DBMET03583 | DBMET03583 | |
| 0.009 | 0.835 | 0.262 | Transcription factor STAT inhibitor | 0.262 0.079 DB03904 | DB03904 | |
| 0.007 | 0.833 | 0.131 | Pregnane X receptor agonist | 0.131 0.098 DB03904 | DB03904 | |
| 0.003 | 0.829 | 0.109 | Tyrosine-protein kinase receptor antagonist | 0.109 0.098 DB03904 | DB03904 | |
| 0.004 | 0.831 | 0.129 | Activin receptor-like kinase 2 inhibitor | 0.129 0.086 DB03904 | DB03904 | |
| 0.001 | 0.828 | 0.04 | AMPA 3 receptor antagonist | 0.04 0.014 DB03904 0.025 0.024 DBMET03583 | DB03904 | |
| 0.007 | 0.835 | 0.139 | I kappa B kinase 1 inhibitor | 0.139 0.011 DB03904 | DB03904 | |
| 0.004 | 0.832 | 0.064 | Dopamine beta hydroxylase inhibitor | 0.047 0.038 DBMET00449 0.064 0.012 DB03904 0.064 0.011 DBMET03583 | DBMET03583 | |
| 0.005 | 0.833 | 0.268 | MAP kinase kinase 2 inhibitor | 0.173 0.102 DBMET00449 0.268 0.046 DB03904 | DB03904 | |
| 0.002 | 0.832 | 0.031 | Calcium-sensing receptor agonist | 0.031 0.013 DB03904 | DB03904 | |
| 0.002 | 0.833 | 0.057 | Dihydrofolate reductase inhibitor | 0.057 0.012 DB03904 | DB03904 | |
| 0.005 | 0.836 | 0.088 | Bromodomain-containing protein 2 inhibitor | 0.087 0.062 DBMET00449 0.088 0.059 DB03904 | DB03904 | |
| 0.003 | 0.835 | 0.168 | NMDA receptor agonist | 0.13 0.011 DBMET03582 0.168 0.006 DB03904 0.125 0.012 DBMET03583 | DB03904 | |
| 0.002 | 0.836 | 0.084 | Protein kinase (CK2) beta inhibitor | 0.068 0.005 DBMET00449 0.084 0.004 DBMET03581 0.041 0.011 DB03904 | DBMET03581 | |
| 0.014 | 0.849 | 0.33 | Tumour necrosis factor antagonist | 0.33 0.013 DBMET00449 0.163 0.085 DBMET03581 0.177 0.07 DB03904 | DBMET00449 | |
| 0.014 | 0.849 | 0.192 | Histone acetyltransferase inhibitor | 0.192 0.082 DB03904 | DB03904 | |
| 0.001 | 0.837 | 0.059 | Alpha 1d adrenoreceptor agonist | 0.059 0.011 DB03904 | DB03904 | |
| 0.003 | 0.839 | 0.234 | LIM domain kinase 1 inhibitor | 0.234 0.046 DB03904 | DB03904 | |
| 0.008 | 0.845 | 0.154 | Carbonic anhydrase XV inhibitor | 0.154 0.029 DB03904 0.115 0.051 DBMET03583 | DB03904 | |
| 0.001 | 0.839 | 0.036 | Retinoid X alpha receptor agonist | 0.036 0.023 DBMET03583 | DBMET03583 | |
| 0.006 | 0.844 | 0.154 | MAP3K7 inhibitor | 0.154 0.009 DB03904 | DB03904 | |
| 0.004 | 0.842 | 0.219 | Calpain inhibitor | 0.219 0.095 DB03904 | DB03904 | |
| 0.008 | 0.847 | 0.208 | Ca2+/calmodulin-dependent kinase II beta inhibitor | 0.208 0.071 DB03904 | DB03904 | |
| 0.001 | 0.841 | 0.05 | Kainate receptor 2 antagonist | 0.05 0.016 DB03904 0.033 0.028 DBMET03583 | DB03904 | |
| 0.004 | 0.845 | 0.201 | Protein kinase (CK1) gamma inhibitor | 0.201 0.044 DB03904 | DB03904 | |
| 0.002 | 0.843 | 0.042 | CDK5/p25 inhibitor | 0.042 0.027 DB03904 | DB03904 | |
| 0.004 | 0.845 | 0.088 | NMDA 2B receptor antagonist | 0.088 0.018 DBMET03581 | DBMET03581 | |
| 0.046 | 0.888 | 0.268 | 5 Hydroxytryptamine 3E antagonist | 0.201 0.06 DBMET00449 0.174 0.123 DBMET03581 0.268 0.01 DB03904 0.192 0.077 DBMET03583 | DB03904 | |
| 0.001 | 0.844 | 0.04 | Cyclin E2 inhibitor | 0.04 0.012 DB03904 | DB03904 | |
| 0.001 | 0.844 | 0.08 | Dopamine D5 agonist | 0.08 0.006 DB03904 0.058 0.013 DBMET03583 | DB03904 | |
| 0.001 | 0.847 | 0.061 | Kainate receptor antagonist | 0.061 0.015 DB03904 0.048 0.023 DBMET03583 | DB03904 | |
| 0.004 | 0.852 | 0.073 | Potassium channel intermediate-conductance Ca-activated blocker | 0.073 0.023 DB03904 | DB03904 | |
| 0.002 | 0.85 | 0.042 | Glutamate (mGluR5) agonist | 0.042 0.038 DBMET03581 | DBMET03581 | |
| 0.003 | 0.851 | 0.111 | TRKA antagonist | 0.111 0.076 DB03904 | DB03904 | |
| 0.004 | 0.853 | 0.115 | MAP kinase kinase inhibitor | 0.106 0.088 DBMET00449 0.107 0.088 DBMET03581 0.115 0.079 DB03904 | DB03904 | |
| 0.011 | 0.86 | 0.117 | NADPH oxidase inhibitor | 0.117 0.086 DB03904 | DB03904 | |
| 0.006 | 0.857 | 0.117 | Trypsin inhibitor | 0.117 0.012 DB03904 | DB03904 | |
| 0.001 | 0.853 | 0.018 | Alpha 2a adrenoreceptor agonist | 0.018 0.011 DB03904 | DB03904 | |
| 0.001 | 0.854 | 0.031 | 11-Beta-hydroxysteroid dehydrogenase 2 inhibitor | 0.031 0.016 DB03904 | DB03904 | |
| 0.004 | 0.857 | 0.239 | Lipoxygenase inhibitor | 0.239 0.108 DB03904 | DB03904 | |
| 0 | 0.855 | 0.016 | CXC chemokine 4 receptor agonist | 0.016 0.009 DB03904 | DB03904 | |
| 0.003 | 0.858 | 0.075 | CDC7 inhibitor | 0.075 0.039 DB03904 | DB03904 | |
| 0.002 | 0.857 | 0.063 | Histamine H1 receptor agonist | 0.063 0.007 DB03904 | DB03904 | |
| 0.003 | 0.86 | 0.053 | Thromboxane synthase inhibitor | 0.053 0.041 DB03904 | DB03904 | |
| 0.002 | 0.862 | 0.073 | Glutamate receptor agonist | 0.073 0.06 DB03904 | DB03904 | |
| 0.005 | 0.865 | 0.054 | Sphingosine 1-phosphate receptor 5 agonist | 0.054 0.037 DBMET03586 0.054 0.036 DBMET03585 | DBMET03585 | |
| 0.006 | 0.866 | 0.11 | 5 Hydroxytryptamine 3 agonist | 0.11 0.011 DB03904 | DB03904 | |
| 0.003 | 0.863 | 0.169 | Aryl hydrocarbon receptor agonist | 0.169 0.121 DB03904 | DB03904 | |
| 0.004 | 0.865 | 0.186 | Urease inhibitor | 0.186 0.012 DB03904 | DB03904 | |
| 0.001 | 0.864 | 0.028 | NMDA receptor glycine site antagonist | 0.028 0.014 DB03904 | DB03904 | |
| 0.005 | 0.868 | 0.076 | Aldosterone antagonist | 0.076 0.012 DB03904 | DB03904 | |
| 0.001 | 0.866 | 0.027 | MAP3K8 inhibitor | 0.027 0.026 DB03904 | DB03904 | |
| 0.004 | 0.87 | 0.037 | Integrin alpha5beta1 antagonist | 0.037 0.035 DBMET03582 | DBMET03582 | |
| 0.006 | 0.872 | 0.073 | Phosphodiesterase 7A inhibitor | 0.056 0.028 DBMET00449 0.073 0.009 DBMET03581 | DBMET03581 | |
| 0.011 | 0.878 | 0.264 | Neuropeptide Y2 antagonist | 0.174 0.173 DBMET03582 0.264 0.043 DB03904 | DB03904 | |
| 0.002 | 0.871 | 0.068 | Histamine agonist | 0.068 0.021 DB03904 | DB03904 | |
| 0.001 | 0.87 | 0.024 | Complement factor D inhibitor | 0.024 0.005 DB03904 | DB03904 | |
| 0.004 | 0.874 | 0.263 | 5 Hydroxytryptamine 3A agonist | 0.189 0.018 DBMET00449 0.126 0.051 DBMET03581 0.263 0.005 DB03904 | DB03904 | |
| 0.001 | 0.871 | 0.061 | NMDA 2C receptor antagonist | 0.061 0.043 DB03904 | DB03904 | |
| 0.002 | 0.874 | 0.034 | Dipeptidyl peptidase IX inhibitor | 0.034 0.005 DBMET03581 | DBMET03581 | |
| 0.012 | 0.885 | 0.088 | Phosphodiesterase 7B inhibitor | 0.088 0.073 DBMET00449 | DBMET00449 | |
| 0.002 | 0.875 | 0.067 | Alpha 1 adrenoreceptor antagonist | 0.067 0.061 DBMET00449 | DBMET00449 | |
| 0.002 | 0.874 | 0.074 | Alpha 1a adrenoreceptor antagonist | 0.074 0.048 DBMET00449 | DBMET00449 | |
| 0.002 | 0.876 | 0.019 | Dipeptidyl peptidase VIII inhibitor | 0.019 0.007 DBMET03581 | DBMET03581 | |
| 0.024 | 0.898 | 0.402 | Tyrosine 3 hydroxylase inhibitor | 0.188 0.158 DBMET00449 0.21 0.119 DBMET03581 0.296 0.035 DBMET03582 0.402 0.008 DB03904 0.384 0.01 DBMET03583 | DB03904 | |
| 0.011 | 0.888 | 0.129 | Glutamate (mGluR7) agonist | 0.129 0.023 DB03904 0.099 0.062 DBMET03583 | DB03904 | |
| 0.001 | 0.878 | 0.062 | Glucagon receptor antagonist | 0.053 0.009 DBMET03582 0.062 0.007 DBMET03583 | DBMET03583 | |
| 0.003 | 0.88 | 0.068 | Histone deacetylase SIRT3 inhibitor | 0.068 0.031 DB03904 | DB03904 | |
| 0.004 | 0.882 | 0.175 | Cyclin-dependent kinase 8 inhibitor | 0.175 0.056 DB03904 | DB03904 | |
| 0 | 0.879 | 0.006 | CC chemokine 6 receptor agonist | 0.006 0.005 DB03904 | DB03904 | |
| 0.004 | 0.886 | 0.044 | VCAM-1 antagonist | 0.044 0.015 DBMET03582 0.043 0.017 DBMET03583 | DBMET03582 | |
| 0.004 | 0.886 | 0.044 | VCAM antagonist | 0.044 0.015 DBMET03582 0.043 0.017 DBMET03583 | DBMET03582 | |
| 0.004 | 0.886 | 0.174 | Neuropeptide Y1 antagonist | 0.156 0.056 DBMET03582 0.174 0.035 DB03904 | DB03904 | |
| 0.009 | 0.891 | 0.202 | HIV-1 integrase (Overall Integration) inhibitor | 0.086 0.069 DBMET00449 0.082 0.075 DBMET03582 0.202 0.011 DB03904 0.144 0.027 DBMET03583 | DB03904 | |
| 0.004 | 0.887 | 0.123 | Heat shock protein 90 alpha antagonist | 0.123 0.122 DBMET00449 | DBMET00449 | |
| 0.001 | 0.885 | 0.036 | Nicotinic alpha3beta4 receptor agonist | 0.036 0.013 DBMET03581 0.034 0.015 DB03904 | DBMET03581 | |
| 0.002 | 0.886 | 0.048 | AMPA 4 receptor antagonist | 0.045 0.019 DB03904 0.048 0.017 DBMET03583 | DBMET03583 | |
| 0.003 | 0.888 | 0.059 | 5 Hydroxytryptamine 5A antagonist | 0.059 0.047 DB03904 | DB03904 | |
| 0.031 | 0.917 | 0.142 | Sphingosine 1-phosphate receptor 2 agonist | 0.142 0.031 DBMET03586 0.142 0.031 DBMET03585 | DBMET03585 | |
| 0.002 | 0.89 | 0.069 | Collagenase 3 inhibitor | 0.069 0.032 DBMET00449 | DBMET00449 | |
| 0.005 | 0.893 | 0.197 | Polo-like kinase-3 inhibitor | 0.197 0.047 DB03904 | DB03904 | |
| 0.003 | 0.892 | 0.052 | 5 Hydroxytryptamine 5 antagonist | 0.052 0.051 DB03904 | DB03904 | |
| 0.003 | 0.892 | 0.045 | Complement factor 1s inhibitor | 0.045 0.003 DB03904 | DB03904 | |
| 0.002 | 0.895 | 0.049 | Histamine H4 receptor antagonist | 0.049 0.032 DB03904 | DB03904 | |
| 0.004 | 0.898 | 0.093 | Myeloperoxidase inhibitor | 0.093 0.044 DB03904 | DB03904 | |
| 0.003 | 0.9 | 0.086 | Phosphodiesterase VII inhibitor | 0.056 0.052 DBMET00449 0.086 0.021 DBMET03581 | DBMET03581 | |
| 0.003 | 0.899 | 0.157 | Inducible nitric-oxide synthase inhibitor | 0.125 0.023 DBMET03582 0.099 0.038 DB03904 0.157 0.015 DBMET03583 | DBMET03583 | |
| 0.002 | 0.899 | 0.076 | Epithelial sodium channel blocker | 0.076 0.014 DB03904 | DB03904 | |
| 0.005 | 0.903 | 0.08 | MDM2 inhibitor | 0.073 0.032 DBMET00449 0.08 0.02 DB03904 | DB03904 | |
| 0.001 | 0.901 | 0.094 | Granulocyte macrophage colony stimulating factor antagonist | 0.094 0.079 DB03904 | DB03904 | |
| 0.001 | 0.901 | 0.019 | Imidazoline I1 receptor antagonist | 0.019 0.016 DB03904 | DB03904 | |
| 0.004 | 0.905 | 0.112 | Mineralocorticoid receptor antagonist | 0.112 0.007 DB03904 | DB03904 | |
| 0.002 | 0.904 | 0.033 | Glutamate (mGluR4) agonist | 0.033 0.025 DB03904 | DB03904 | |
| 0.001 | 0.905 | 0.052 | Nerve growth factor antagonist | 0.052 0.016 DB03904 | DB03904 | |
| 0.005 | 0.91 | 0.194 | Neurotensin receptor agonist | 0.142 0.123 DBMET00449 0.163 0.074 DBMET03582 0.194 0.038 DB03904 0.191 0.04 DBMET03583 | DB03904 | |
| 0.001 | 0.909 | 0.074 | 5 Hydroxytryptamine 2A agonist | 0.074 0.033 DB03904 | DB03904 | |
| 0.004 | 0.911 | 0.049 | CC chemokine 4 receptor antagonist | 0.049 0.03 DB03904 | DB03904 | |
| 0.002 | 0.91 | 0.055 | Complement C3a chemotactic receptor antagonist | 0.055 0.024 DBMET03582 0.046 0.029 DB03904 0.049 0.027 DBMET03583 | DBMET03582 | |
| 0.001 | 0.91 | 0.049 | AMPA receptor antagonist | 0.049 0.032 DB03904 | DB03904 | |
| 0.001 | 0.91 | 0.024 | Methionyl aminopeptidase 2 inhibitor | 0.024 0.019 DB03904 | DB03904 | |
| 0.002 | 0.911 | 0.099 | NMDA receptor antagonist | 0.099 0.048 DBMET03583 | DBMET03583 | |
| 0.003 | 0.915 | 0.212 | I kappa B kinase epsilon inhibitor | 0.212 0.061 DB03904 | DB03904 | |
| 0.001 | 0.913 | 0.038 | Protein kinase (CK1) epsilon inhibitor | 0.038 0.029 DB03904 | DB03904 | |
| 0.001 | 0.915 | 0.1 | Alpha 1d adrenoreceptor antagonist | 0.1 0.023 DBMET00449 | DBMET00449 | |
| 0.003 | 0.917 | 0.112 | I kappa B kinase 2 inhibitor | 0.06 0.047 DBMET03581 0.112 0.009 DB03904 | DB03904 | |
| 0.001 | 0.915 | 0.027 | 5 Hydroxytryptamine 6 agonist | 0.027 0.024 DB03904 | DB03904 | |
| 0.002 | 0.917 | 0.127 | CYP2A6 inhibitor | 0.127 0.024 DB03904 | DB03904 | |
| 0.005 | 0.92 | 0.074 | Immunoglobulin Fc receptor antagonist | 0.074 0.008 DB03904 | DB03904 | |
| 0.001 | 0.916 | 0.027 | Protease (Human cytomegalovirus) inhibitor | 0.027 0.009 DB03904 | DB03904 | |
| 0.002 | 0.919 | 0.2 | Focal adhesion kinase 2 inhibitor | 0.2 0.069 DB03904 | DB03904 | |
| 0.001 | 0.919 | 0.119 | Alpha 1b adrenoreceptor antagonist | 0.119 0.029 DBMET00449 | DBMET00449 | |
| 0.016 | 0.935 | 0.088 | CC chemokine 5 receptor agonist | 0.088 0.042 DB03904 | DB03904 | |
| 0.004 | 0.924 | 0.08 | Glutamate (mGluR4) antagonist | 0.08 0.008 DB03904 0.055 0.017 DBMET03583 | DB03904 | |
| 0.002 | 0.924 | 0.144 | I kappa B kinase inhibitor | 0.144 0.018 DB03904 | DB03904 | |
| 0.001 | 0.923 | 0.039 | Endothelial nitric-oxide synthase inhibitor | 0.029 0.024 DB03904 0.039 0.014 DBMET03583 | DBMET03583 | |
| 0.002 | 0.925 | 0.066 | Glutamate (mGluR group III) antagonist | 0.066 0.01 DB03904 0.049 0.022 DBMET03583 | DB03904 | |
| 0.004 | 0.926 | 0.252 | Transcription factor STAT3 inhibitor | 0.252 0.082 DB03904 | DB03904 | |
| 0.002 | 0.925 | 0.024 | Sodium/hydrogen exchanger inhibitor | 0.024 0.006 DB03904 | DB03904 | |
| 0.003 | 0.926 | 0.142 | Nitric-oxide synthase inhibitor | 0.101 0.059 DBMET03582 0.107 0.049 DB03904 0.142 0.026 DBMET03583 | DBMET03583 | |
| 0.003 | 0.927 | 0.337 | Kinesin antagonist | 0.145 0.005 DBMET03581 0.082 0.01 DBMET03582 0.179 0.004 DB03904 0.337 0.003 DBMET03583 | DBMET03583 | |
| 0.003 | 0.927 | 0.337 | Kinesin-like protein 1 inhibitor | 0.145 0.005 DBMET03581 0.082 0.01 DBMET03582 0.179 0.004 DB03904 0.337 0.003 DBMET03583 | DBMET03583 | |
| 0.003 | 0.927 | 0.228 | Check point kinase 2 inhibitor | 0.228 0.012 DB03904 | DB03904 | |
| 0.003 | 0.928 | 0.075 | Neuropeptide Y antagonist | 0.075 0.067 DB03904 | DB03904 | |
| 0.003 | 0.929 | 0.255 | 5 Hydroxytryptamine 1E antagonist | 0.255 0.07 DB03904 | DB03904 | |
| 0.002 | 0.928 | 0.051 | Dipeptidyl peptidase IV inhibitor | 0.05 0.021 DBMET00449 0.051 0.02 DBMET03581 0.046 0.027 DB03904 | DBMET03581 | |
| 0.001 | 0.928 | 0.045 | 5 Hydroxytryptamine 2B agonist | 0.045 0.017 DB03904 | DB03904 | |
| 0.003 | 0.935 | 0.035 | AMPA receptor agonist | 0.035 0.025 DBMET00449 | DBMET00449 | |
| 0.002 | 0.934 | 0.045 | Tryptophan 5 hydroxylase inhibitor | 0.045 0.008 DB03904 0.044 0.01 DBMET03583 | DB03904 | |
| 0.004 | 0.937 | 0.021 | Complement factor 1 inhibitor | 0.021 0.007 DB03904 | DB03904 | |
| 0.002 | 0.937 | 0.044 | Glutamate (mGluR group III) agonist | 0.044 0.028 DB03904 0.039 0.035 DBMET03583 | DB03904 | |
| 0.002 | 0.938 | 0.086 | Polo-like kinase-1 inhibitor | 0.086 0.069 DB03904 | DB03904 | |
| 0.001 | 0.937 | 0.061 | Cyclin A1 inhibitor | 0.061 0.036 DB03904 | DB03904 | |
| 0.002 | 0.938 | 0.08 | Dipeptidyl peptidase inhibitor | 0.058 0.029 DBMET00449 0.08 0.014 DBMET03581 0.054 0.035 DB03904 | DBMET03581 | |
| 0.006 | 0.942 | 0.331 | Insulysin inhibitor | 0.19 0.173 DBMET00449 0.253 0.093 DBMET03582 0.331 0.042 DB03904 0.295 0.062 DBMET03583 | DB03904 | |
| 0.004 | 0.943 | 0.024 | Complement factor 1r inhibitor | 0.024 0.023 DB03904 | DB03904 | |
| 0.006 | 0.946 | 0.207 | 3C-like protease (Human coronavirus) inhibitor | 0.134 0.131 DBMET00449 0.207 0.048 DB03904 | DB03904 | |
| 0.002 | 0.944 | 0.047 | Dipeptidyl peptidase I inhibitor | 0.047 0.009 DBMET03581 | DBMET03581 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |